DK159115B - A LOGIC PROCEDURE FOR PREPARING A KETAL OR THIOKETAL DERIVATIVE OF A MERCAPTOACYL PROLINE - Google Patents

A LOGIC PROCEDURE FOR PREPARING A KETAL OR THIOKETAL DERIVATIVE OF A MERCAPTOACYL PROLINE Download PDF

Info

Publication number
DK159115B
DK159115B DK550079A DK550079A DK159115B DK 159115 B DK159115 B DK 159115B DK 550079 A DK550079 A DK 550079A DK 550079 A DK550079 A DK 550079A DK 159115 B DK159115 B DK 159115B
Authority
DK
Denmark
Prior art keywords
proline
give
formula
oxopropyl
methyl
Prior art date
Application number
DK550079A
Other languages
Danish (da)
Other versions
DK550079A (en
DK159115C (en
Inventor
John Krapcho
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK550079A publication Critical patent/DK550079A/en
Publication of DK159115B publication Critical patent/DK159115B/en
Application granted granted Critical
Publication of DK159115C publication Critical patent/DK159115C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/10Spiro-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

DK 159115BDK 159115B

iin

Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af et ketal- eller thioketalderi-vat af en mercaptoacylprolin med den almene formel IThe present invention relates to an analogous process for the preparation of a ketal or thioketal derivative of a mercaptoacyl proline of the general formula I

5 R1 R2 X1 X2 R3 O f \ (I) * I II I *15 R1 R2 X1 X2 R3 O f \ (I) * I II I * 1

R1-S- (CH2) m-CH-C-N--C-COORR1-S- (CH2) m-CH-C-N - C-COOR

10 H10 H

hvori R betyder hydrogen eller C^-Cyalkyl, R3 betyder hydrogen, C^Cy-alkyl eller halogen-C1-C7-alkyl/ X1 og X2 betyder oxygen eller svovl, 15 R1 og R2 betyder C^Cy-alkyl, eller R1 og R2 betyder tilsammen en polymethylenkæde, således at der dannes en 5- eller 6-leddet ring, m betyder 0, 1 eller 2, og R1 betyder hydrogen, C2-C8-alkanoyl, benzoyl eller en gruppe 20 R1 R2 I, 15 X1 X2 R3 0 / \wherein R is hydrogen or C 1 -C 6 alkyl, R 3 is hydrogen, C 1 -C 6 alkyl or halo-C 1 -C 7 alkyl / X 1 and X 2 is oxygen or sulfur, R 1 and R 2 are C 1 R2 together represents a polymethylene chain such that a 5- or 6-membered ring is formed, m represents 0, 1 or 2, and R1 represents hydrogen, C2-C8 alkanoyl, benzoyl or a group 20 R1 R2 I, 15 X1 X2 R3 0 / \

I II I * II II I * I

-S- (CH2) m-CH-C-N-C-COOR-S- (CH2) m-CH-C-N-C-COOR

25 H25 H

hvori R, R1, R2, R3, X1, X2 og m har de ovenfor angivne betydninger, således at der dannes en bis-symmetrisk disul-fidforbindelse.wherein R, R1, R2, R3, X1, X2 and m have the above meanings so as to form a bis-symmetric disulphide compound.

Stjernen i ovenstående formel viser et asymmetricenter 30 i ringen. Dette center har L-konfiguration.The star of the above formula shows an asymmetric center 30 in the ring. This center has L configuration.

Asymmetriske centre kan også forekomme i mercaptoacyl-sidekæden afhængigt af definitionen af R3. Et andet asymmetricenter kan også forekomme i ringen, når X-'—R1 og X2-R2 er forskellige. Produkterne kan derfor forekomme i stereo-35 isomere former eller som racemiske blandinger heraf. Alle disse kan fremstilles ved fremgangsmåden ifølge opfindelsen.Asymmetric centers may also occur in the mercaptoacyl side chain, depending on the definition of R3. Another asymmetric center may also occur in the ring when X-R1 and X2-R2 are different. The products may therefore be present in stereoisomeric forms or as racemic mixtures thereof. All of these can be prepared by the process of the invention.

DK 159115 BDK 159115 B

22

Den nedenfor beskrevne syntese kan benytte sig af racematet eller en af de enantiomere som udgangsmaterialer. Når der •anvendes racemisk udgangsmateriale til syntesen, kan de stereoisomere, der fås i slutproduktet, adskilles ved gængse 5 chromatografiske metoder eller fraktioneret krystallisation. Dersom der findes et asymmetricenter i mercaptoacylsidekæden, er dette fortrinsvis i D-konfiguration.The synthesis described below may use the racemate or one of the enantiomers as starting materials. When racemic starting material is used for the synthesis, the stereoisomers obtained in the final product can be separated by conventional chromatographic methods or fractional crystallization. If an asymmetric center exists in the mercaptoacyl side chain, this is preferably in D configuration.

De forbindelser, der fremstilles ved fremgangsmåden ifølge opfindelsen, er mercaptoacylderivaterne af prolin 10 med formlen I ovenfor, hvilke forbindelser er nyttige anti--hypertensive midler, idet de har en inhiberende virkning på angiotensin-omdannende enzym.The compounds prepared by the process of the invention are the mercaptoacyl derivatives of proline 10 of formula I above, which are useful anti-hypertensive agents, having an inhibitory effect on angiotensin-converting enzyme.

Fra dansk patentansøgning nr. 596/77 kendes nært beslægtede forbindelser med samme virkning, især forbindel-15 sen, som er i handelen under navnet Captopril. Forbindelserne fremstillet ifølge opfindelsen udviser imidlertid en overraskende forøget virkning i forhold til de således kendte forbindelser.Danish Patent Application No. 596/77 discloses closely related compounds having the same effect, especially the compound which is commercially available under the name Captopril. However, the compounds of the invention exhibit a surprisingly increased effect over the compounds thus known.

Udtrykket alkyl, som det anvendes i definitionerne 20 af symbolerne R, R1, R2 og R3 er ligekædede eller forgrenede carbonhydridgrupper med op til 7 carbonatomer, f.eks. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl og isopentyl. De foretrukne alkylgrupper har op til fire carbonatomer, idet methyl og ethyl er særlig foretrukket.The term alkyl as used in the definitions 20 of the symbols R, R1, R2 and R3 are straight or branched hydrocarbon groups having up to 7 carbon atoms, e.g. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl and isopentyl. The preferred alkyl groups have up to four carbon atoms, with methyl and ethyl being particularly preferred.

25 På lignende måde refererer udtrykkene alkoxy og alkylthio til sådanne alkylgrupper, der er knyttet til et oxygeneller svovlatom.Similarly, the terms alkoxy and alkylthio refer to such alkyl groups attached to an oxygen or sulfur atom.

Udtrykket halogen-substitueret alkyl refererer til sådanne alkylgrupper, der er beskrevet ovenfor, hvor et 30 eller flere hydrogenatomer er erstattet af chlor-, brom eller fluoratomer såsom trifluormethyl, pentafluorethyl, 2,2,2-trichlorethyl, chlormethyl og brommethyl.The term halogen-substituted alkyl refers to such alkyl groups described above, wherein one or more hydrogen atoms are replaced by chlorine, bromine or fluorine atoms such as trifluoromethyl, pentafluoroethyl, 2,2,2-trichloroethyl, chloromethyl and bromomethyl.

Som R5 foretrækkes alkanoylgrupper med op til fire carbonatomer, især acetyl, og benzoyl.As R5, alkanoyl groups having up to four carbon atoms, especially acetyl, and benzoyl are preferred.

35 Foretrukne forbindelser med formlen I er det L-prolin- -holdige derivat, hvor R er hydrogen.Preferred compounds of formula I are the L-proline-containing derivative wherein R is hydrogen.

DK 159115BDK 159115B

33

Med hensyn til mercaptoacylsidekæden foretrækkes som slutprodukter sådanne forbindelser, hvor R5 er hydrogen, m er 0 eller 1, og R3 er hydrogen, alkyl med 1-4 carbonatomer, især methyl, eller trifluormethyl. Foretrukket er ligeledes 5 både som mellemprodukter og slutprodukter de ovennævnte sidekæder, hvor R5 er alkanoyl med 2-4 carbonatomer, især acetyl, eller benzoyl.With respect to the mercaptoacyl side chain, as final products, such compounds are preferred where R 5 is hydrogen, m is 0 or 1 and R 3 is hydrogen, alkyl of 1-4 carbon atoms, especially methyl, or trifluoromethyl. Also preferred, both as intermediates and end products, are the aforementioned side chains wherein R 5 is alkanoyl of 2-4 carbon atoms, especially acetyl, or benzoyl.

Særlig foretrukne som slutprodukter er forbindelser med formlen I med en mercaptoacylsidekæde, hvor R5 er hydro-10 gen, m er 1, R3 er methyl, og det asymmetriske carbonatom, hvortil R3 er knyttet, er i D-konfiguration.Particularly preferred as end products are compounds of formula I having a mercaptoacyl side chain wherein R 5 is hydrogen, m is 1, R 3 is methyl, and the asymmetric carbon atom to which R 3 is attached is in D-configuration.

Foretrukne med hensyn til substituenterne på prolin-ringen er sådanne forbindelser, hvor X1 og X2 er ens, især sådanne, hvor X^—R1 og X2-R2 begge er methoxy eller begge 15 ethoxy, eller X^R1 og X2-R2 tilsammen danner en gruppe H2c - ch2 / h2c - CH2 ,Preferred with respect to the substituents on the proline ring are such compounds where X 1 and X 2 are the same, especially those where X 1 -R 1 and X 2 -R 2 are both methoxy or both ethoxy or X 1 R 1 and X 2 -R 2 together form a group H2c - ch2 / h2c - CH2,

0 0 SS0 0 SS

ν' ν' 20 CH2 CH2 ^^CH2 eller S^S 4 o 25 Fremgangsmåden ifølge opfindelsen til fremstilling20 CH2 CH2 ^^ CH2 or S ^ S 4 o 25 The process of the invention for preparation

af forbindelserne med formlen I er ejendommelig ved, at en substitueret prolin med formlen IIof the compounds of formula I is characterized in that a substituted proline of formula II

R1 R2 γΐ γ2R1 R2 γΐ γ2

\ S\ S

30 (II) h2cX ?h2 I λ *(II) h2cX? H2 I λ *

HN-C-C00RHN-C-C00R

HH

hvori R, R1, R2, X1 og X2 har de ovenfor angivne betydninger,wherein R, R1, R2, X1 and X2 have the above meanings,

35 kobles med en syre med formlen III35 is coupled with an acid of formula III

DK 159115 BDK 159115 B

4 R3 R,5-S-(CH2)m-CH-COOH (III) hvori R'5 betyder C2-C8-alkanoyl eller benzoyl,4 R 3 R 5-S- (CH 2) m-CH-COOH (III) wherein R 5 represents C 2 -C 8 alkanoyl or benzoyl,

5 eller et reaktivt derivat deraf, såsom et syrechlorid, til dannelse af en forbindelse med formlen IV5 or a reactive derivative thereof, such as an acid chloride, to form a compound of formula IV

R1 R2 X1 X2 10 / f i? r J <IV>R1 R2 X1 X2 10 / f i? r J <IV>

R' 5-S- (CH2) m-CH-C-N-C-COORR '5-S- (CH 2) m-CH-C-N-C-COOR

i hvorefter om ønsket gruppen R'5 fjernes til dannelse af en 15 forbindelse med formlen I, hvori R5 betyder hydrogen, og denne forbindelse om ønsket oxideres med iod til den bis--symmetriske disulfidforbindelse.in which, if desired, the group R'5 is removed to form a compound of formula I wherein R5 is hydrogen and, if desired, this compound is oxidized with iodine to the bis-symmetric disulfide compound.

Denne reaktion kan udføres i nærværelse af et koblingsmiddel såsom dicyclohexylcarbodiimid eller lignende, 20 eller syren kan aktiveres ved dannelse af dens blandede anhydrid, symmetriske anhydrid, syrehalogenid, aktive ester eller ved anvendelse af Woodward-reagens K, N-ethoxycarbonyl--2-ethoxy-l,2-dihydroquinolin. eller lignende. Med hensyn til acyleringsmetoder henvises til Methoden der organischen 25 Chemie (Houben-Weyl), bd. XV, 2. del, side 1 ff. (1974). Fortrinsvis omsættes syrehalogenidet, især syrechloridet, med formlen III med en syre med formlen II.This reaction may be carried out in the presence of a coupling agent such as dicyclohexylcarbodiimide or the like, or the acid may be activated by forming its mixed anhydride, symmetric anhydride, acid halide, active ester or using Woodward reagent K, N-ethoxycarbonyl-2-ethoxy. -l, 2-dihydroquinoline. or similar. With regard to acylation methods, see the Method der Organchen 25 Chemie (Houben-Weyl), vol. XV, Part 2, page 1 et seq. (1974). Preferably, the acid halide, especially the acid chloride, of formula III is reacted with an acid of formula II.

Hvis prolinet med formlen II omsættes i esterformen, kan det fremkomne esterprodukt med formlen IV, dvs. R er 30 alkyl, omdannes til den frie syre, dvs. R er hydrogen, ved gængse metoder. Hvis R er éthyl,' kan således den esterbeskyttende gruppe fjernes ved hydrolyse.If the proline of formula II is reacted in the ester form, the resulting ester product of formula IV, i.e. R is 30 alkyl, converted to the free acid, i.e. R is hydrogen, by conventional methods. Thus, if R is ethyl, the ester protecting group can be removed by hydrolysis.

Produktet med formlen IV isoleres og renses fortrinsvis ved krystallisation, f.eks. ved at danne dicyclohexyl-35 aminsaltet og derefter omdanne saltet til den frie syreform ved behandling med en vandig opløsning af en syre såsom 5The product of formula IV is preferably isolated and purified by crystallization, e.g. by forming the dicyclohexyl-amine salt and then converting the salt to the free acid form by treatment with an aqueous solution of an acid such as 5

DK 159115 BDK 159115 B

kaliumhydrogensulfat.potassium bisulfate.

Forbindelsen med formlen IV kan omdannes til produkterne med formlen I, hvor R^ er hydrogen, ved gængs hydrolyse eller ammonolyse.The compound of formula IV may be converted to the products of formula I wherein R 1 is hydrogen by conventional hydrolysis or ammonolysis.

5 Forbindelserne med formlen I, hvor R5 er R1 R2 I, I, V*The compounds of formula I wherein R 5 is R1 R2 I, I, V *

R3 0 NR3 0 N

I II < * 1I II <* 1

10 -S-(CH2)m-CH-C-N-C-COOR-S- (CH 2) m-CH-C-N-C-COOR

HH

fås ved, at en forbindelse med formlen I, hvor R5 er hydrogen, oxideres direkte med iod.is obtained by a compound of formula I wherein R 5 is hydrogen is directly oxidized with iodine.

Esterne med formlen I, hvor R er alkyl, kan opnås ud 15 fra carboxylsyreforbindelserne, dvs. hvor R er hydrogen, ved gængse esterificeringsmetoder, f.eks. ved esterificering med et diazoalkan såsom diazomethan, en l-alkyl-3-p-tolyl-triazen såsom l-n-butyl-3-p-tolyltriazen.The esters of formula I wherein R is alkyl can be obtained from the carboxylic acid compounds, i.e. wherein R is hydrogen, by conventional esterification methods, e.g. by esterification with a diazoalkane such as diazomethane, a 1-alkyl-3-p-tolyl triazene such as 1-n-butyl-3-p-tolyl triazene.

De disubstituerede proliner med formlen II, hvor χΐ-20 —r! og X2-R2 er ens, kan fås ved at omsætte en N-beskyttet ketoforbindelse med formlen Λ C CH0 25 I I 2The disubstituted prolines of formula II, wherein χΐ-20 -r! and X 2 -R 2 are the same can be obtained by reacting an N-protected keto compound of formula Λ C CHO 25 I I 2

Cbz-N-C-COORCbz-N-C-COOR

hvor Cbz er carbobenzyloxy, med en alkohol eller thiol med formlen 30 R1-X1-H (VI) nærværelse af et orthoformiat eller thioformiat med form 2 len HC(X1-R1)3 og en syre såsom koncentreret svovlsyre eller 35 p-toluensulfonsyre. Denne reaktion kan foregå i et inaktivt 3 organisk opløsningsmiddel såsom benzen, eddikesyre, ether,wherein Cbz is carbobenzyloxy, with an alcohol or thiol of formula 30 R1-X1-H (VI) in the presence of an orthoformate or thioformate of formula 2 of HC (X1-R1) 3 and an acid such as concentrated sulfuric acid or 35 p-toluenesulfonic acid. This reaction can take place in an inert organic solvent such as benzene, acetic acid, ether,

DK 159115 BDK 159115 B

6 cyclohexan eller lignende, fortrinsvis under opvarmning, f. eks. til ca. tilbagesvalingstemperatur. Se Buehier m.fl.6 cyclohexane or the like, preferably under heating, e.g. reflux temperature. See Buehier et al.

Survey of Organic Syntheses (Wiley & Sons, 1977), bd. 1, side 516-519. Produktet af denne reaktion er det N-beskyttede 5 mellemprodukt med formlen R1 R1 f f X\ /χ1 10 h2c ^h2 (vii)Survey of Organic Syntheses (Wiley & Sons, 1977), vol. 1, pages 516-519. The product of this reaction is the N-protected intermediate of the formula R1 R1 f f X \ / χ1 10 h2c ^ h2 (vii)

Cbz-N-xC-COORCbz-N-xC-COOR

* i* i

HH

Det N-beskyttede mellemprodukt med formlen VII kan 15 behandles med 1 molækvivalent af en alkohol eller thiol med formlen r2-x2-h (VIII) 20 ifølge de ovenfor beskrevne betingelser, hvilket giver mellemproduktet K1 R2 ? f '1 f 2The N-protected intermediate of formula VII can be treated with 1 mole equivalent of an alcohol or thiol of formula r2-x2-h (VIII) 20 according to the conditions described above to give the intermediate K1 R2? f '1 f 2

X\ ^XX \ ^ X

25 /C\25 / C \

Ii2<J (IX)I2 <J (IX)

Cb z-N-jC-COORCb z-N-jC-COOR

“l"L

HH

30 Ved at anvende et moloverskud af alkoholen eller thiolen med formlen VIII fås mellemproduktet 2 2 f f k > C.By using a molar excess of the alcohol or thiol of formula VIII, the intermediate is obtained 2 2 f f k> C.

E0C^ C.EU (χ) 2| I 2E0C ^ C.EU (χ) 2 | I 2

Cbz-N-xC-COORCbz-N-xC-COOR

*1* 1

HH

DK 159115BDK 159115B

77

Den N-beskyttende gruppe kan derefter fjernes ved gængse metoder, f.eks. når X1 og X2 begge er oxygen, ved hydrogeno-lyse i nærværelse af palladium-carbon-katalysator, eller når det ene af eller begge symbolerne X1 og X2 er svovl, 5 ved behandling med HBr og eddikesyre, hvilket giver de di-substituerede forbindelser med formlen II.The N-protecting group can then be removed by conventional methods, e.g. when X1 and X2 are both oxygen, by hydrogenolysis in the presence of palladium carbon catalyst, or when one or both of the symbols X1 and X2 are sulfur, 5 by treatment with HBr and acetic acid to give the di-substituted compounds of formula II.

På lignende måde kan spireforbindelserne med formlen II (dvs. R1 og R2 er forenet i en polymethylenkæde) fås ved at omsætte ketoforbindelsen med formlen V med en alkohol 10 eller thiol med formlen (ch2)t xlX Xx2 (XI)Similarly, the germ compounds of formula II (i.e., R 1 and R 2 are joined in a polymethylene chain) can be obtained by reacting the keto compound of formula V with an alcohol 10 or thiol of formula (ch 2) t xlX Xx2 (XI)

I II I

Η HΗ H

hvor t betyder 2 eller 3, i nærværelse af en syre såsom p-15 -toluensulfonsyre, hvilket giver mellemproduktet <%>t é x2 \ ^ (XII) (Η2?^ "Wgwhere t means 2 or 3, in the presence of an acid such as p-15-toluenesulfonic acid, giving the intermediate <%> t é x2 \ ^ (XII) (Η2?

20 I20 I

• Cbz-N--C-C00R• Cbz-N - C-C00R

HH

Alternativt kan den disubstituerede forbindelse med formlen VII behandles direkte med et moloverskud af alkoholen 25 eller thiolen med formlen XI, hvilket giver mellemproduktet med formlen xii.Alternatively, the disubstituted compound of formula VII can be treated directly with a molar excess of the alcohol 25 or thiol of formula XI to give the intermediate of formula xii.

Som beskrevet ovenfor, kan den N-beskyttende gruppe derefter fjernes, hvilket giver spiroforbindelserne med formlen II.As described above, the N-protecting group can then be removed to give the spiro compounds of formula II.

30 Som en alternativ metode kan indførelsen af grup- 11 2 2 perne X -R og X -R ske senere i rækkefølgen. Ifølge denne ændring behandles den beskyttede ketoforbindelse med formlen 030 As an alternative method, the introduction of groups X-R and X-R can occur later in the sequence. According to this change, the protected keto compound of formula 0 is treated

IIII

α 35 H,C CH, <XIII> 2| I 2α 35 H, C CH, <XIII> 2 | I 2

H-N-—C-COOHH-N - C-COOH

HH

DK 159115 BDK 159115 B

8 som derefter acyleres med syren, fortrinsvis syrehalogenidet med formlen III, hvorved fås en forbindelse med formlen 5 £ R3 0 'Η2^Υ2)9 (XIV)8 which is then acylated with the acid, preferably the acid halide of Formula III, to give a compound of Formula 5 (R3 O 'Η2 ^ Υ2) 9 (XIV)

R' J-S- (CH2) -C-C-N-—C-COOHR 'J-S- (CH 2) -C-C-N -— C-COOH

HH

10 112 210 112 2

Grupperne X -R og X -R eller spirogruppen (CH2>t x1 x2 X/ 15 kan derefter indføres på dette tidspunkt ved de ovenfor beskrevne- metoder; hvilket giver et produkt med formlen IV.The groups X -R and X -R or the spiro group (CH2> t x1 x2 X / 15 can then be introduced at this time by the methods described above to give a product of formula IV.

Der henvises til de følgende litteratursteder med hensyn til yderligere metoder til fremstilling af udgangsmaterialer og mellemprodukter: USA patentskrifterne nr.Reference is made to the following literature sites for further methods of preparing starting materials and intermediates: United States Patent Nos.

20 4.046.889, 4.105.776, 4.154.935 og 4.116.962, Can.J.Biochem.20,046,889, 4,105,776, 4,154,935 and 4,116,962, Can.J.Biochem.

& Physiol. 37, 584 (1959), J.A.C.S. 79, 189 (1957), J.Med.& Physiol. 37, 584 (1959), J.A.C.S. 79, 189 (1957), J.Med.

Chem. 21, 445 (1978), Aus. J. Chem. 20, 1493-1509 (1967),Chem. 21, 445 (1978), Aus. J. Chem. 20, 1493-1509 (1967),

Buehier m.fl., Survey of Organic Syntheses (Wiley & Sons, 1977), bd. 1, side 516-519, bd. 2, side 461-470, Chem.Pharm.Buehier et al., Survey of Organic Syntheses (Wiley & Sons, 1977), vol. 1, pages 516-519, vol. 2, pages 461-470, Chem.Pharm.

25 Bull., Tokyo 26, 2209 og 2217 (1978), Can.J.Chem. 47, 860, (1969), J.Amer.Chem.Soc., 80, 6350 (1958), Harrisonm.fi., Compendium or Organic Synthetic Methods (Wiley-lnterscience,25 Bull., Tokyo 26, 2209 and 2217 (1978), Can.J.Chem. 47, 860, (1969), J. Amer.Chem.Soc., 80, 6350 (1958), Harrisonm.fi., Compendium or Organic Synthetic Methods (Wiley lnterscience,

New York, 1971), side 449-456, J.Amer.Chem.Soc., 79, 192 (1956), Bull.Soc.Chem., 1965(8), side 2253-2259, J.Org.Chem.New York, 1971), pages 449-456, J.Amer.Chem.Soc., 79, 192 (1956), Bull.Soc.Chem., 1965 (8), pages 2253-2259, J.Org.Chem.

30 25, side 521-530 (1960).25, pp. 521-530 (1960).

De deri beskrevne metoder kan anvendes som almene metoder ved syntesen af forbindelserne og adskillelsen af de isomere, der kan anvendes ved fremgangsmåden ifølge den foreliggende opfindelse. Yderligere detaljer findes i eksemp- 35 lerne, der tjener som model for fremstillingen af andre forbindelser i gruppen.The methods described therein can be used as general methods in the synthesis of the compounds and the separation of the isomers which can be used in the process of the present invention. Further details can be found in the examples which serve as a model for the preparation of other compounds in the group.

DK 159115BDK 159115B

99

Forbindelserne, der fremstilles ved fremgangsmåden ifølge opfindelsen, danner basiske salte med en lang række uorganiske eller organiske baser. Det saltdannende ion, der stammer fra sådanne baser, kan være metalioner, f.eks. alu-5 minium, alkalimetalioner såsom natrium- eller kaliumjordalka-limetalioner såsom calcium eller magnesium eller et aminsalt-ion, hvoraf der kendes flere til dette formål f.eks. aralkyl-aminer såsom dibenzylamin, Ν,Ν-dibenzylethylendiamin, lavere alkylaminer såsom methylamin, t-butylamin, procain, lavere 10 alkylpiperidiner såsom N-ethylpiperidin, cycloalkylaminer såsom cyclohexylamin eller dicyclohexylamin, 1-adamantanamin, benzathin eller salte, der stammer fra aminosyrer såsom argi-nin, lysin eller lignende. De fysiologisk acceptable salte kan anvendes medicinsk som beskrevet nedenfor og foretrækkes.The compounds prepared by the process of the invention form basic salts with a wide variety of inorganic or organic bases. The salt-forming ion emanating from such bases may be metal ions, e.g. aluminum, alkali metal ions such as sodium or potassium alkaline earth metal ions such as calcium or magnesium or an amine salt ion, several of which are known for this purpose e.g. aralkylamines such as dibenzylamine, Ν, Ν-dibenzylethylenediamine, lower alkylamines such as methylamine, t-butylamine, procaine, lower alkylpiperidines such as N-ethylpiperidine, cycloalkylamines such as cyclohexylamine or dicyclohexylamine, 1-adamantanamine, benzathine or benzathine arginine, lysine or the like. The physiologically acceptable salts can be used medically as described below and preferred.

15 Saltene fremstilles ved at omsætte syreformen af forbindelsen med 1 ækvivalent af den base, der giver den ønskede basiske ion i et medium, hvori saltet udfældes, eller i et vandigt medium med påfølgende lyophilisering. Den frie syreform kan fås ud fra saltet ved gængse neutralisationsmetoder, f.eks.The salts are prepared by reacting the acid form of the compound with 1 equivalent of the base which gives the desired basic ion in a medium in which the salt precipitates, or in an aqueous medium with subsequent lyophilization. The free acid form can be obtained from the salt by conventional neutralization methods, e.g.

20 med kaliumbisulfat eller saltsyre.20 with potassium bisulfate or hydrochloric acid.

Forbindelsen med formlen I er, især når R5 er hydrogen, anvendelige som hypotensive midler. De hæmmer omdannelsen af decapeptidet angiotensin I til angiotensin II og er derfor nyttige til lindring af angiotensin-fremkaldt hyper-25 tension. Virkningen af enzymet renin på angiotensinogen, et pseudoglobulin i blodplasma, producerer angiotensin I. Angiotensin I omdannes af det angiotensin-omdannende enzym (ACE) til angiotensin II. Dette er et aktivt pressorstof, der har været under mistanke for at være den fremkaldende årsag til 30 forskellige former for hypertension hos forskellige pattedyrarter, f.eks. rotter og hunde. Forbindelserne, der fremstilles ved fremgangsmåden ifølge opfindelsen, griber ind i angiotensinogen---> (renin)---> angiotensin I---> (ACE)---> angiotensin Il-rækkefølgen ved at hæmme det an- 35 giotensin-omdannende enzym og nedsætte eller eliminere dan-The compound of formula I, especially when R 5 is hydrogen, is useful as hypotensive agents. They inhibit the conversion of the decapeptide angiotensin I to angiotensin II and are therefore useful in alleviating angiotensin-induced hyper tension. The effect of the enzyme renin on angiotensinogen, a blood plasma pseudoglobulin, produces angiotensin I. Angiotensin I is converted by angiotensin converting enzyme (ACE) to angiotensin II. This is an active pressor substance that has been suspected to be the causative cause of 30 different forms of hypertension in various mammalian species, e.g. rats and dogs. The compounds prepared by the process of the invention interfere with the angiotensinogen ---> (renin) ---> angiotensin I ---> (ACE) ---> angiotensin II sequence by inhibiting the angiotensin II sequence. converting enzyme and reducing or eliminating dan-

DK 159115 BDK 159115 B

10 nelsen af pressorstoffet angiotensin II. Man kan således ved indgivelse af et middel indeholdende en eller en kombination af forbindelser med formlen I bedre angiotensin-frem-kaldt hypertension hos pattedyr, der lider heraf. En enkelt 5 dosis, eller fortrinsvis to til fire opdelte daglige doser beregnet ud fra ca. 0,1-100 mg/kg legemsvægt pr. dag, fortrinsvis 1-15 mg/kg/dag, er passende til nedsættelse af blodtryk. Stoffet indgives fortrinsvis oralt, men der kan anvendes parenterale indgivelsesveje såsom subcutant, intra-1° muskulært, intravenøst eller intraperitonealt.The addition of the pressor substance angiotensin II. Thus, by administration of an agent containing one or a combination of compounds of formula I, better angiotensin-induced hypertension in mammals suffering from it may be obtained. A single 5 dose, or preferably two to four divided daily doses calculated from ca. 0.1-100 mg / kg body weight per day, preferably 1-15 mg / kg / day, is appropriate for lowering blood pressure. The drug is preferably administered orally, but parenteral routes of administration such as subcutaneous, intra-1 ° muscular, intravenous or intraperitoneal can be used.

Forbindelserne, der fremstilles ved fremgangsmåden ifølge opfindelsen, kan kombineres med et diuretisk stof til behandling af hypertension. Et kombineret produkt, der omfatter en forbindelse fremstillet ved fremgangsmåden ifølge 15 opfindelsen og et diuretisk stof, kan indgives i effektiv mængde,hvilket for et pattedyr på 70 kg omfatter en samlet daglig dosis på ca. 30-600 mg, fortrinsvis ca. 30-300 mg, af en forbindelse fremstillet ved fremgangsmåden ifølge opfindelsen og ca. 15-300 mg, fortrinsvis 15-200 mg, af et diuretisk 20 stof til et pattedyr, der har behov herfor. Eksempler på di-uretika til anvendelse kombineret med en forbindelse fremstillet ved fremgangsmåden ifølge opfindelsen er thiaziddiu-retika, f.eks. chlorthiazid, hydrcchlorthiazid, flumthiazid, hydroglumthiazid, benzdroflumthiazid, methchlothiazid, tri-25 chlorthiazid, polythiazid eller benzthiazid, samt ethacrynsy-re, ticrynafen, chlorthalidon, furosemid, musolimin, bumeta-nid, triamteren, emilorid og spironolacton samt salte af sådanne forbindelser.The compounds prepared by the method of the invention can be combined with a diuretic for the treatment of hypertension. A combined product comprising a compound prepared by the process of the invention and a diuretic may be administered in effective amount, which for a mammal of 70 kg comprises a total daily dose of about 50 mg. 30-600 mg, preferably approx. 30-300 mg, of a compound prepared by the process of the invention, and ca. 15-300 mg, preferably 15-200 mg, of a diuretic for a mammal in need thereof. Examples of diuretics for use in combination with a compound prepared by the process of the invention are thiazide diuretics, e.g. chlorothiazide, hydrochlorothiazide, flumthiazide, hydroglumthiazide, benzdroflumthiazide, methchlothiazide, trichlorothiazide, polythiazide or benzthiazide;

Forbindelserne med formlen I kan fremstilles til 30 brug ved reduktion af blodtryk i præparater såsom tabletter, kapsler eller eliksirer til oral indgivelse eller i sterile opløsninger eller suspensioner til parenteral indgivelse.The compounds of formula I may be prepared for use in reducing blood pressure in preparations such as tablets, capsules or elixirs for oral administration or in sterile solutions or suspensions for parenteral administration.

Fremgangsmåden ifølge opfindelsen belyses i det føl-35 gende nærmere ved hjælp af eksempler.The process according to the invention will now be elucidated by way of example.

DK 159115 BDK 159115 B

11 p11 p

Eksempel 1 [7(S),8S]-7-[3-(Acetylthio)-2-methyl-l-oxopropylj-l,4-dioxa-7--azaspiro[4,4]nonan-8-carboxylsyre a) N-Carbobenzyloxy-4-hydroxy-L-prolin 26.5 g (0,20 mol) 4-hydroxy-L-prolin og 32,8 mlExample 1 [7 (S), 8S] -7- [3- (Acetylthio) -2-methyl-1-oxopropyl] -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid a) N-Carbobenzyloxy-4-hydroxy-L-proline 26.5 g (0.20 mol) of 4-hydroxy-L-proline and 32.8 ml

OISLAND

(0,23 mol) benzylchlorformiat omsættes i 200 ml vand og 100 ml acetone i nærværelse af 20 g (0,02 mol) kaliumbicarbonat og 69,2 g (0,50 mol) kaliumcarbonat og oparbejdes med 90 ml koncentreret saltsyre som beskrevet i Can.J.Biochem. & Phy-10 siol. 37, 584 (1959), hvorved fås N-carbobenzyloxy-4-hydroxy--L-prolin. Dette produkt omsættes med cyclohexylamin til dannelse af cyclohexylaminsaltet i et udbytte på 69 g, smeltepunkt 193-195°C. Saltet (34 g) neutraliseres med N-saltsyre 2 6 til opnåelse af 27 g fri syre som et farveløst glas. [a] 15 -70°, (c, 1% i chloroform).(0.23 mol) of benzyl chloroformate is reacted in 200 ml of water and 100 ml of acetone in the presence of 20 g (0.02 mol) of potassium bicarbonate and 69.2 g (0.50 mol) of potassium carbonate and worked up with 90 ml of concentrated hydrochloric acid as described in Can.J.Biochem. & Phy-10 siol. 37, 584 (1959) to give N-carbobenzyloxy-4-hydroxy-L-proline. This product is reacted with cyclohexylamine to give the cyclohexylamine salt in a yield of 69 g, mp 193-195 ° C. The salt (34 g) is neutralized with N-hydrochloric acid 26 to give 27 g of free acid as a colorless glass. [α] 15 -70 °, (c, 1% in chloroform).

b) N-Carbobenzyloxy-4-keto-L-prolin 21.5 g (0,81 mol) N-carbobenzyloxy-4-hydroxy-L-pro-lin oxideres i 1,2 liter acetone med 83 ml 8N chromsyre i svovlsyre som beskrevet i J.A.C.S. 79, 189 (1957). For at 2Q lette den efterfølgende filtrering af chromsalte tilsættes 30 g "Celite" (diatoméjord) til acetoneopløsningen før indførelse af oxideringsmidlet. Der anvendes en luftomrører. Reaktiofxsblandingen filtreres, og acetonefiltratet inddampes til ca. 300 ml før fortynding med 1 liter chloroform. Op-25 løsningen vaskes med 300 ml mættet natriumchlorid (fire gange) , tørres (MgSO^), filtreres, og opløsningsmidlet afdampes, hvilket giver 22,8 g N-carbobenzyloxy-4-keto-L-prolin, der krystalliseres ud fra 50 ml ether-150 ml hexan, hvorved fås 17,2 g produkt (81%), smeltepunkt 99-101°C, [a]^ +17° (c, 30 1% i chloroform).b) N-Carbobenzyloxy-4-keto-L-proline 21.5 g (0.81 mol) of N-carbobenzyloxy-4-hydroxy-L-proline is oxidized in 1.2 liters of acetone with 83 ml of 8N chromic acid in sulfuric acid as described in JACS 79, 189 (1957). To facilitate 2Q the subsequent filtration of chromium salts, 30 g of "Celite" (diatomaceous earth) is added to the acetone solution before introducing the oxidizing agent. An air stirrer is used. The reaction mixture is filtered and the acetone filtrate is evaporated to ca. 300 ml before dilution with 1 liter of chloroform. The solution is washed with 300 ml of saturated sodium chloride (four times), dried (MgSO 4), filtered and the solvent is evaporated to give 22.8 g of N-carbobenzyloxy-4-keto-L-proline crystallized from 50 ether-150 ml hexane to give 17.2 g of product (81%), mp 99-101 ° C, [α] 25 + 17 ° (c, 1% in chloroform).

c) N-Carbobenzyloxy-4,4-ethylendioxy-L-prolinc) N-Carbobenzyloxy-4,4-ethylenedioxy-L-proline

En omrørt blanding af 12,8 g (0,049 mol) N-carbo-benzyloxy-4-keto-L-prolin, 53 ml (0,095 mol) ethylenglycol og 0,35 g p-toluensulfonsyre.i^O i 1,31 liter benzen opvarmes, 35 og den fremkomne opløsning tilbagesvales i 7 timer (det dannede vand opsamles i et Dean-Stark-apparat). Efter henstandA stirred mixture of 12.8 g (0.049 mol) of N-carbo-benzyloxy-4-keto-L-proline, 53 ml (0.095 mol) of ethylene glycol and 0.35 g of p-toluenesulfonic acid in 1.31 liters benzene is heated, and the resulting solution is refluxed for 7 hours (the resulting water is collected in a Dean-Stark apparatus). After standing

OISLAND

DK 159115 BDK 159115 B

12 natten over ved stuetemperatur skilles det nederste glycollag fra, og benzenopløsningen vaskes med 150 ml mættet natrium-chlorid, tørres (MgS04), og opløsningsmidlet afdampes, hvilket giver 14,6 g N-carbobenzyloxy-4,4-ethylendioxy-L-prolin 5 som en sirupsagtig remanens. Denne opløses i 60 ml ethanol, filtreres, behandles med 5 g cyclohexylamin og fortyndes med ether. Ved podning og gnidning skilles det krystallinske cyclohexylaminsalt fra; vægt efter afkøling natten over 9,0 g, smeltepunkt 179-180°C (begynder 173°C). Materialet om-10 krystalliseres ud fra acetonitril, smeltepunkt 182-184°C (begynder 179°C), [a]^* -21° (c, 1% i EtOH) .12 overnight at room temperature the lower glycol layer is separated and the benzene solution is washed with 150 ml of saturated sodium chloride, dried (MgSO 4) and the solvent is evaporated to give 14.6 g of N-carbobenzyloxy-4,4-ethylenedioxy-L-proline 5 as a syrupy remnant. This is dissolved in 60 ml of ethanol, filtered, treated with 5 g of cyclohexylamine and diluted with ether. By grafting and rubbing, the crystalline cyclohexylamine salt is separated; weight after cooling overnight 9.0 g, m.p. 179-180 ° C (starting 173 ° C). The material is recrystallized from acetonitrile, m.p. 182-184 ° C (beginning 179 ° C), [α] D -21 ° (c, 1% in EtOH).

8,4 g af cyclohexylaminsaltet suspenderes i 40 ml ethylacetat, omrøres, afkøles og behandles med IN saltsyre. Lagene adskilles, den vandige fase ekstraheres med med yder-15 ligere 3 x 40 ml ethylacetat, de forenede organiske lag tørres (MgS04), og opløsningsmidlet afdampes, til slut ved 0,2 mm. Den sirupsagtige remanens, der begynder at krystallisere, gnides under ether, og etheren afdampes, hvilket giver 6,4 g (42%) næsten farveløst N-carbobenzyloxy-4,4-ethylen-20 dioxy-L-prolin, smeltepunkt 101-103°C (begynder 98°C) , [a]^* -34° (c, 1% i CHC13).8.4 g of the cyclohexylamine salt is suspended in 40 ml of ethyl acetate, stirred, cooled and treated with 1N hydrochloric acid. The layers are separated, the aqueous phase is extracted with additional 3 x 40 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.2 mm. The syrupy residue which begins to crystallize is rubbed under ether and the ether is evaporated to give 6.4 g (42%) of almost colorless N-carbobenzyloxy-4,4-ethylene-20-dioxy-L-proline, m.p. ° C (beginning 98 ° C), [α] D -34 ° (c, 1% in CHCl13).

d) 4,4-Ethylendioxy-L-prolind) 4,4-Ethylenedioxy-L-proline

En opløsning af 3,2 g (0,0104 mol) N-carbobenzyloxy-4 ,4-ethylendioxy-L-prolin i 100 ml methanol/vand (2:1) 25 behandles med 1 g 5% palladium-carbon og rystes på Parr-hydro-genator i 6 timer. Katalysatoren filtreres fra under nitrogen, vaskes med methanol, og de forenede filtrater inddampes, til sidst ved 0,1-0,2 mm, hvilket giver 1,7 g (94%) farveløst fast 4,4-ethylendioxy-L-prolin, smeltepunkt 245-247°C (søn-30 derdeliiig) , [a]^* -32° (c, 0,5% i 1:1 MeOH-^O) .A solution of 3.2 g (0.0104 mole) of N-carbobenzyloxy-4,4-ethylenedioxy-L-proline in 100 ml of methanol / water (2: 1) is treated with 1 g of 5% palladium carbon and shaken Parr hydrogenator for 6 hours. The catalyst is filtered off under nitrogen, washed with methanol and the combined filtrates are evaporated, finally at 0.1-0.2 mm to give 1.7 g (94%) of colorless solid 4,4-ethylenedioxy-L-proline. mp 245-247 ° C (dec.), [α] D -32 ° (c, 0.5% in 1: 1 MeOH + O).

e) [7(S),8S]-7-[3-(Acetylthio)-2-methyl-l-oxopropyl]-1,4-di-oxa-7-azaspiro[4,4]nonan-8-carboxylsyree) [7 (S), 8S] -7- [3- (Acetylthio) -2-methyl-1-oxopropyl] -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid

En omrørt opløsning af 3,2 g 4,4-ethylendioxy-L--prolin (0,0185 mol) i 50 ml vand afkøles til 5°C og behand-35 les portionsvis med fast natriumcarbonat til pH 8,5. Derefter tilsættes under fortsat omrøring og afkøling en opløs- 13A stirred solution of 3.2 g of 4,4-ethylenedioxy-L-proline (0.0185 mole) in 50 ml of water is cooled to 5 ° C and treated portionwise with solid sodium carbonate to pH 8.5. Then, with continued stirring and cooling, a solution 13 is added

OISLAND

DK 159115 BDK 159115 B

ning af 3,7 g (0,020 mol) D-3-acetylthio-2-methylpropanoyl-chlorid i 5 ml ether portionsvis, idet pH holdes på 8,5 med 25% natriumcarbonatopløsning (ca. 14 ml). Efter 1 1/4 times forløb behandles opløsningen med 50 ml ethylacetat, omrøres, 5 afkøles, gøres forsigtigt sur med saltsyre (1:1) til pH 2,0, mættes med natriumchlorid, og lagene adskilles. Den vandige fase ekstraheres med yderligere 3 x 50 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes til sidst ved 0,2 mm. Den faste remanens gnides under 10 ether, og afdampningen gentages, hvorved der fås 5,9 g (100%) [7(S),8S]-7-[3-(acetylthio)-2-methyl-l-oxopropyl]-l,4-dioxa--7-azaspiro[4,4]nonan-8-carboxylsyre, smeltepunkt 108-111°C.3.7 g (0.020 mol) of D-3-acetylthio-2-methylpropanoyl chloride in 5 ml of ether in portions, maintaining the pH of 8.5 with 25% sodium carbonate solution (about 14 ml). After 1 1/4 hour, the solution is treated with 50 ml of ethyl acetate, stirred, cooled, gently acidified with hydrochloric acid (1: 1) to pH 2.0, saturated with sodium chloride and the layers separated. The aqueous phase is extracted with an additional 3 x 50 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is finally evaporated at 0.2 mm. The solid residue is rubbed under 10 ether and the evaporation is repeated to give 5.9 g (100%) of [7 (S), 8S] -7- [3- (acetylthio) -2-methyl-1-oxopropyl] - 1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid, m.p. 108-111 ° C.

Produktet omdannes til dicyclohexylaminsaltet med 3,4 g dicyclohexylamin i 70 ml ethylacetat. Ved podning og 15 gnidning udfældes det krystallinske salt og omkrystalliseres ud fra 95 ml acetonitril, udbytte 6,7 g, smeltepunkt 187-189°C (begynder ved 184°C) , [ot]^ -59° (c, 1% i EtOH) .The product is converted to the dicyclohexylamine salt with 3.4 g of dicyclohexylamine in 70 ml of ethyl acetate. Upon inoculation and rubbing, the crystalline salt is precipitated and recrystallized from 95 ml of acetonitrile, yield 6.7 g, m.p. 187-189 ° C (beginning at 184 ° C), [.alpha. EtOH).

Dicyclohexylaminsaltet omdannes til den frie syre ved at blive suspenderes i ethylacetat og behandles med 75 20 ml 10% kaliumbisulfat og omrøring, indtil der fås to lag.The dicyclohexylamine salt is converted to the free acid by suspending in ethyl acetate and treated with 75 ml of 10% potassium bisulfate and stirring until two layers are obtained.

Efter adskillelse' ekstraheres den vandige fase med 4 x 75 ml ethylacetat, de organiske lag forenes, tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 4,1 g farveløst [7(S),— 8S]-7-[3-(acetylthio)-2-methyl-l-oxopropyl]-1,4-dioxa-7-aza-25 spiro[4,4]nonan-8-carboxylsyre, smeltepunkt 120-122°C, begynder ved 117°C, [<x]2d5 -118° (c, 1% i EtOH).After separation, the aqueous phase is extracted with 4 x 75 ml of ethyl acetate, the organic layers are combined, dried (MgSO 4) and the solvent is evaporated to give 4.1 g of colorless [7 (S), - 8S] -7- [3 - (acetylthio) -2-methyl-1-oxopropyl] -1,4-dioxa-7-aza-spiro [4,4] nonane-8-carboxylic acid, mp 120-122 ° C, starts at 117 ° C, [α] 25 D -118 ° (c, 1% in EtOH).

Eksempel 2 [7(S), 8S]-7-(3-Mercapto-2-methyl-l-oxopropyl)-l,4-dioxa-7-30 -azaspiro[4,4]nonan-8-carboxylsyreExample 2 [7 (S), 8S] -7- (3-Mercapto-2-methyl-1-oxopropyl) -1,4-dioxa-7-30-azaspiro [4,4] nonane-8-carboxylic acid

Argon ledes gennem en kold opløsning af 8,5 ml koncentreret ammoniumhydroxid i 20 ml vand. 4,0 g (0,013 mol) [7(S),8S]— 7—(3—(acetylthio)-2-methyl-l-oxopropyl]-1,4-dioxo- -7-azaspiro-[4,4]nonan-8-carboxylsyre fra eksempel 1 (e) til-35 sættes derefter, og blandingen omrøres i isbad i nogle få minutter og derefter ved stuetemperatur under argon i 2 timer.Argon is passed through a cold solution of 8.5 ml of concentrated ammonium hydroxide in 20 ml of water. 4.0 g (0.013 mol) [7 (S), 8S] - 7- (3- (acetylthio) -2-methyl-1-oxopropyl] -1,4-dioxo-7-azaspiro [4.4 ] nonan-8-carboxylic acid from Example 1 (e) is then added and the mixture is stirred in an ice bath for a few minutes and then at room temperature under argon for 2 hours.

OISLAND

DK 159115 BDK 159115 B

1414

Opløsningen behandles med 30 ml ethylacetat, afkøles, omrøres og gøres sur med 16 ml saltsyre (1:1). Lagene adskilles, den vandige fase ekstraheres med yderligere 30 ml ethylacetat (to gange), ethylacetatekstrakterne forenes, tørres 5 (MgS04), og opløsningsmidlet afdampes, hvilket giver E7(S),— 8S]-7-(3-mercapto-2-methyl-l-oxopropyl)-l,4-dioxa-7-azaspiro-[4,4]nonan-8-carboxylsyre som en fast remanens. Produktet gnides under ether, og afdampningen gentages. Derefter tri-tureres produktet med 30 ml hexan, afkøles 1 time, filtreres 10 un-er argon og tørres i vakuum, hvilket giver 2,7 g farveløs fast [7(S),8S]-7-(3-mercapto-2-methyl-l-oxopropyl)-l,4-dioxa--7-azaspiro[4,4]nonan-8-carboxylsyre, smeltepunkt 131-133°C (begynder 125°C) , [a]^ -66° (c, 1% i EtOH) .The solution is treated with 30 ml of ethyl acetate, cooled, stirred and acidified with 16 ml of hydrochloric acid (1: 1). The layers are separated, the aqueous phase is extracted with an additional 30 ml of ethyl acetate (twice), the ethyl acetate extracts are combined, dried (MgSO 4) and the solvent is evaporated to give E7 (S), - 8S] -7- (3-mercapto-2 methyl-1-oxopropyl) -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid as a solid residue. The product is rubbed under ether and the evaporation repeated. Then, the product is triturated with 30 ml of hexane, cooled for 1 hour, filtered for 10 ounces of argon and dried in vacuo to give 2.7 g of colorless solid [7 (S), 8S] -7- (3-mercapto-2 -methyl-1-oxopropyl) -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid, mp 131-133 ° C (beginning 125 ° C), [α] c, 1% in EtOH).

15 Eksempel 3 (S)-1-[(3-Acetylthio)-2-methyl-l-oxoprbpyl]-4,4-dimethoxy-L- -prolin a) N-Carbobenzyloxy-4,4-dimethoxy -L-prolin-methylesterExample 3 (S) -1 - [(3-Acetylthio) -2-methyl-1-oxoprbpyl] -4,4-dimethoxy-L-proline a) N-Carbobenzyloxy-4,4-dimethoxy-L-proline methyl ester

En omrørt opløsning af 7,8 q (0,03 mol) N-carbo-20 benzyloxy-4-keto-L-prolin fra eksempel 1 i 60 ml methanol behandles med 96 ml trimethylorthoformiat efterfulgt af 0,6 ml koncentreret svovlsyre og henstår natten over ved stuetemperatur .A stirred solution of 7.8 g (0.03 mole) of N-carbo-20-benzyloxy-4-keto-L-proline from Example 1 in 60 ml of methanol is treated with 96 ml of trimethyl orthoformate followed by 0.6 ml of concentrated sulfuric acid and left overnight at room temperature.

Den bleggule opløsning omrøres, behandles med 1,5 g 25 kaliumcarbonat efterfulgt af 30 ml vand, og størstedelen af opløsningsmidlet fjernes på en roterende fordamper, hvilket giver en sirupsagtig remanens, der rystes med 30 ml vand og 30 ml chloroform. Efter at lagene er adskilt, ekstraheres den vandige fase med yderligere chloroform (3 x 30 ml), og de 30 forenede organiske lag vaskes med 45 ml mættet natriumchlo- ridopløsning og tørres (MgSO^). Afdampning af opløsningsmidlet giver 8,4 g (88%) N-carbobenzyloxy-4,4-dimethoxy-L-pro-lin-methylester.The pale yellow solution is stirred, treated with 1.5 g of potassium carbonate followed by 30 ml of water and the majority of the solvent removed on a rotary evaporator to give a syrupy residue which is shaken with 30 ml of water and 30 ml of chloroform. After the layers are separated, the aqueous phase is extracted with additional chloroform (3 x 30 ml) and the 30 combined organic layers are washed with 45 ml of saturated sodium chloride solution and dried (MgSO 4). Evaporation of the solvent gives 8.4 g (88%) of N-carbobenzyloxy-4,4-dimethoxy-L-proline methyl ester.

b) N-Carbobenzyloxy-4,4-dimethoxy-L-prolin 35 8,4 g (0,026 mol) af esteren fra del (a) opløses i 80 ml methanol, behandles dråbevis ved -1°C til 4°C med 18 ml (0,036 mol) 2N natriumhydroxid, holdes på 0°C i en time ogb) N-Carbobenzyloxy-4,4-dimethoxy-L-proline 35.4 g (0.026 mol) of the ester of part (a) is dissolved in 80 ml of methanol, treated dropwise at -1 ° C to 4 ° C with 18 ml (0.036 mol) of 2N sodium hydroxide, maintained at 0 ° C for one hour and

DK 159115BDK 159115B

1515

OISLAND

ved stuetemperatur natten over. Efter at ca. halvdelen af opløsningsmidlet er fjernes på en roterende fordamper, fortyndes opløsningen med 150 ml vand, vaskes med 100 ml ether (vaskevæsken kasseres), gøres sur under afkøling med 63 ml 5 1:1 saltsyre til pH 2 og ekstraheres med 4 x 750 ml ethyla- cetat. De forenede eks.trakter vaskes med 50 ml mættet na-triumchloridopløsning, tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 8,0 g af en bleggul viskos olie.at room temperature overnight. After approx. half of the solvent is removed on a rotary evaporator, diluted with 150 ml of water, washed with 100 ml of ether (the wash liquid is discarded), acidified with cooling with 63 ml of 5 1: 1 hydrochloric acid to pH 2 and extracted with 4 x 750 ml of ethylene - cetate. The combined extracts are washed with 50 ml of saturated sodium chloride solution, dried (MgSO 4) and the solvent is evaporated to give 8.0 g of a pale yellow viscous oil.

Olien opløses i 35 ml ethanol, behandles med 3,0 g cyclohexyl-10 amin i 10 ml ethanol og fortyndes til 500 ml med ether. Ved podning og gnidning udskilles det krystallinske N-carboben-zyloxy-4,4-dimethoxy-L-prolin-cyclohexylaminsalt, der efter afkøling natten over vejer 7,0 g, smeltepunkt 157-159°C (begynder 151°C) , [a]^6 -34° (c, 1% i EtOH) . Dette materiale 15 omkrystalliseres ud fra 100 ml acetonitril, hvilket giver saltet som et farveløst fast stof, smeltepunkt 158-160°C (s, 154°C) , [a]^6 -33° (c, 1% i EtOH).The oil is dissolved in 35 ml of ethanol, treated with 3.0 g of cyclohexyl-10 amine in 10 ml of ethanol and diluted to 500 ml with ether. Upon grafting and rubbing, the crystalline N-carbobenzyloxy-4,4-dimethoxy-L-proline-cyclohexylamine salt, which after weighing 7.0 g, is separated out, m.p. 157-159 ° C (starts 151 ° C), [ [α] 6 -34 ° (c, 1% in EtOH). This material is recrystallized from 100 ml of acetonitrile to give the salt as a colorless solid, mp 158-160 ° C (s, 154 ° C), [α] 6 -33 ° (c, 1% in EtOH).

N-Carbobenzyloxy-4,4-dimethoxy-L-prolin-cyclohexyl-aminsaltet suspenderes i 40 ml ethylacetat, omrøres og be-20 handles med 25 ml IN saltsyre. Når der er opnået to klare lag, adskilles de, den vandige fase ekstraheres med yderligere 3 x 40 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, til sidst ved 0,2 mm og 40°C, hvilket giver 7,2 g (70%) N-carbobenzyloxy-4,4-di-25 methoxy-L-prolin som en bleggul viskos sirup.The N-Carbobenzyloxy-4,4-dimethoxy-L-proline-cyclohexylamine salt is suspended in 40 ml of ethyl acetate, stirred and treated with 25 ml of 1N hydrochloric acid. When two clear layers are obtained, they are separated, the aqueous phase is extracted with an additional 3 x 40 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.2 mm and 40 ° C, gives 7.2 g (70%) of N-carbobenzyloxy-4,4-dimethoxy-L-proline as a pale yellow viscous syrup.

c) 4,4-Dimethoxy-L-prolinc) 4,4-Dimethoxy-L-proline

En opløsning af 72 g (0,022 mol) N-carbobenzyloxy--4,4-dimethoxy-L-prolin i 210 ml methanol/vand (2:'l) behandles med 2,3 g 5% palladium-carbon og rystes på en Parr-hydro-30 genator i 6 timer. Katalysatoren filtreres fra under· nitrogen, vaskes med methanol, og de forenede filtrater inddampes, til sidst ved 0,1-0,2 mm, hvilket giver en delvis krystallinsk remanens. Denne remanens tages op i 200 ml methanol, og ind-dampningen gentages. Når det faste stof er gnedet under ether 35 (inddampning gentages igen) fås der 3,6 g (95%) næsten farveløst 4,4-dimethoxy-L-prolin, smeltepunkt 192-194°C (sønderdeling), [cc]^6 -47° (c, 1% i MeOH) .A solution of 72 g (0.022 mol) of N-carbobenzyloxy - 4,4-dimethoxy-L-proline in 210 ml of methanol / water (2: 1) is treated with 2.3 g of 5% palladium carbon and shaken on a Parr Hydrogenator for 6 hours. The catalyst is filtered off under nitrogen, washed with methanol and the combined filtrates are evaporated, finally at 0.1-0.2 mm to give a partially crystalline residue. This residue is taken up in 200 ml of methanol and the evaporation is repeated. When the solid is rubbed under ether 35 (evaporation is repeated again) 3.6 g (95%) is obtained almost colorless 4,4-dimethoxy-L-proline, mp 192-194 ° C (dec.), [Cc] 6 -47 ° (c, 1% in MeOH).

JJ

DK 159115 BDK 159115 B

OISLAND

1616

En prøve, der er krystalliseret ud fra methanol/e-ther, er farveløs og smelter ved 197-198°C (sønderdeling) [< -49°; (c, 1% i MeOH) .A sample crystallized from methanol / ether is colorless and melts at 197-198 ° C (dec.) [<-49 °; (c, 1% in MeOH).

d) (S) -1- [3- (Acetylthio) -2-methyl-l-oxopropylj -4,4-dimeth-5 oxy-L-prolind) (S) -1- [3- (Acetylthio) -2-methyl-1-oxopropyl] -4,4-dimethoxy-L-proline

En omrørt opløsning af 3,3 g (0,019 mol) 4,4-di-methoxy-L-prolin i 50 ml vand afkøles til 5°C og bringes på pH 8,5 ved tilsætning af 25% natriumcarbonatopløsning (vægt/ volumen). Derefter tilsættes portionsvis under fortsat om-10 røring og afkøling en opløsning af 3,8 g (0,021 mol) D-3--acetylthio-2-methylpropanoylchlorid i 5 ml ether, medens pH holdes på 7,5-8,5 ved dråbevis tilsætning af 25% natriumcarbonatopløsning. Når pH er stabiliseret ved 8,2-8,4 (efter ca. 15 minutter), fortsættes omrøring og afkøling i i alt 15 en time. Opløsningen vaskes derefter med 50 ml ethylacetat (vaskevæsken kasseres), dækkes med et lag af 50 ml ethylacetat, afkøles, omrøres, gøres forsigtigt sur med 1:1 saltsyre til pH 2,0, mættes med natriumchlorid, og lagene adskilles.A stirred solution of 3.3 g (0.019 mol) of 4,4-di-methoxy-L-proline in 50 ml of water is cooled to 5 ° C and brought to pH 8.5 by the addition of 25% sodium carbonate solution (w / v). . Then, with continued stirring and cooling, a solution of 3.8 g (0.021 mole) of D-3-acetylthio-2-methylpropanoyl chloride in 5 ml of ether is added while maintaining the pH of 7.5-8.5 by dropwise addition. addition of 25% sodium carbonate solution. When the pH is stabilized at 8.2-8.4 (after about 15 minutes), stirring and cooling for a total of 15 an hour are continued. The solution is then washed with 50 ml of ethyl acetate (the wash liquid is discarded), covered with a layer of 50 ml of ethyl acetate, cooled, stirred, gently acidified with 1: 1 hydrochloric acid to pH 2.0, saturated with sodium chloride and the layers separated.

Den vandige fase ekstraheres med yderligere 3 x 50 ml ethyl-20 acetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, til sidst ved 0,2 mm, hvilket giver 6,7 g sirupsagtigt produkt. Denne sirup behandles i 70 ml ethylacetat med 3,9 g dicyclohexylamin, hvilket giver 6,5 g farveløst (S)-1-[3-(acetylthio)-2-methyl-l-oxopropyl]-4,4-dimeth-25 oxy-L-prolin-dicyclohexylaminsalt i udbytter på 3,1 g og 3,4 g, smeltepunkt 158-160°C (begynder ved 145°C), [a]^ -71° (c, 1% i EtOH).The aqueous phase is extracted with an additional 3 x 50 ml of ethyl 20 acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.2 mm to give 6.7 g of syrupy product. This syrup is treated in 70 ml of ethyl acetate with 3.9 g of dicyclohexylamine to give 6.5 g of colorless (S) -1- [3- (acetylthio) -2-methyl-1-oxopropyl] -4,4-dimeth-25 oxy-L-proline dicyclohexylamine salt in yields of 3.1 g and 3.4 g, m.p. 158-160 ° C (beginning at 145 ° C), [α] 25 -71 ° (c, 1% in EtOH).

Efter omkrystallisation ud fra 20 ml varm ethylacetat og 60 ml hexan vejer det farveløse faste salt 6,0 g, 30 smeltepunkt 158-166°C (begynder 155°C) , [a]^ -69° (c, 1% i EtOH) .After recrystallization from 20 ml of hot ethyl acetate and 60 ml of hexane, the colorless solid salt weighs 6.0 g, m.p. 158-166 ° C (starts 155 ° C), [α] 25 -69 ° (c, 1% in EtOH ).

Dicyclohexylaminsaltet omdannes til den frie syre ved at suspendere 5,0 g i 50 ml ethylacetat, afkøle det og behandle med 60 ml 10% kaliumbisulfatopløsning, hvilket giver 35 2 klare lag. Efter adskillelse ekstraheres den vandige fase med 3 x 50 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, til sidst ved 0,1-0,2 17The dicyclohexylamine salt is converted to the free acid by suspending 5.0 g in 50 ml of ethyl acetate, cooling it and treating with 60 ml of 10% potassium bisulfate solution to give 2 clear layers. After separation, the aqueous phase is extracted with 3 x 50 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.1-0.2

OISLAND

DK 159115 BDK 159115 B

mm og 45°C, hvilket giver 4,1 g (69%) (S)-l-[3-(acetylthio)- -2-methyl-l-oxopropyl]-4,4-dimethoxy-L-prolin som et viskost 25 o næsten glaslignende materiale, [a] -112 (c, 1% i EtOH).mm and 45 ° C to give 4.1 g (69%) of (S) -1- [3- (acetylthio) -2-methyl-1-oxopropyl] -4,4-dimethoxy-L-proline as a viscous 25 o almost glass-like material, [a] -112 (c, 1% in EtOH).

5 Eksempel 4 (S)-1-(3-Mercapto-2-methyl-l-oxopropyl)-4,4-dimethoxy-L-prolin Der ledes argon gennem en kold opløsning af 8,5 ml koncentreret ammoniumhydroxid i 20 ml vand i 0,25 time. Denne tilsættes under afkøling og argontæppe til 4,1 g (0,013 10 mol) (S)-1-[3-(acetylthio)-2-methyl-l-oxopropyl]-4,4-dimethoxy-L-prolin, og blandingen hvirvles om i isbad, indtil der fås en svagt gul opløsning (ca. 15 minutter). Omrøringen under argon fortsættes ved stuetemperatur i yderligere 2 timer, derefter ekstraheres opløsningen med 30 ml ethylacetat (den-15 ne og følgende operationer udføres i så stor udstrækning som muligt under argonatmosfære). Det vandige lag afkøles, omrøres, overdækkes med et lag af 30 ml ethylacetat, gøres portionsvis surt med 16 ml 1:1 saltsyre. Lagene adskilles, den vandige fase ekstraheres med yderligere 3 x 30 ml ethylacet-20 at, de forenede ethylacetatlag tørres (MgS04), og opløsningsmidlet afdampes, hvilket giver 3,5 g (100%) (S)-1-(3-mercap- to-2-methyl-l-oxopropyl)-4,4-dimethoxy-L-prolin som en far- 25 o veløs viskos sirup, [a] D -72 (c, 1% i EtOH).Example 4 (S) -1- (3-Mercapto-2-methyl-1-oxopropyl) -4,4-dimethoxy-L-proline Argon is passed through a cold solution of 8.5 ml of concentrated ammonium hydroxide in 20 ml of water for 0.25 hours. This is added under cooling and argon blanket to 4.1 g (0.013 10 moles) of (S) -1- [3- (acetylthio) -2-methyl-1-oxopropyl] -4,4-dimethoxy-L-proline, and the mixture swirl in an ice bath until a pale yellow solution is obtained (about 15 minutes). Stirring under argon is continued at room temperature for an additional 2 hours, then the solution is extracted with 30 ml of ethyl acetate (these and the following operations are carried out as far as possible under argon atmosphere). The aqueous layer is cooled, stirred, covered with a layer of 30 ml of ethyl acetate, acidified portionwise with 16 ml of 1: 1 hydrochloric acid. The layers are separated, the aqueous phase is extracted with an additional 3 x 30 ml of ethyl acetate, the combined ethyl acetate layers are dried (MgSO 4) and the solvent is evaporated to give 3.5 g (100%) of (S) -1- (3-mercap - (2-methyl-1-oxopropyl) -4,4-dimethoxy-L-proline as a colorless velvic viscous syrup, [α] D -72 (c, 1% in EtOH).

Denne forbindelse (3,4 g) tritureres med 20 ml ethyl-25 acetat, gnides, fortyndes med 30 ml hexan og afkøles, hvorved fås et farveløst fast stof, der vejer 2,6 g, smeltepunkt 108-110°C, [a]2D5 -77° (c, 1% i EtOH).This compound (3.4 g) is triturated with 20 ml of ethyl acetate, rubbed, diluted with 30 ml of hexane and cooled to give a colorless solid weighing 2.6 g, mp 108-110 ° C. ] D -77 ° (c, 1% in EtOH).

Eksempel 5 30 (S)-1-[3-(Åcetylthio)-2-methyl-l-oxopropylj-4,4-diethoxy-L- -prolin a) N-Carbobenzyloxy-4,4-diethoxy-L-prolin-ethylesterExample 5 (S) -1- [3- (Acetylthio) -2-methyl-1-oxopropyl] -4,4-diethoxy-L-proline a) N-Carbobenzyloxy-4,4-diethoxy-L-proline ethyl ester

Ved at følge fremgangsmåden i eksempel 3(a), men anvende triethylorthoformiat i stedet for trimethylorthofor-35 miat og ethanol i stedet for methanol fås 10,8 g N-carboben-zyloxy-4,4-diethoxy-L-prolin-ethylester som en gul olie.Following the procedure of Example 3 (a) but using triethyl orthoformate instead of trimethyl orthoformate and ethanol instead of methanol, 10.8 g of N-carbobenzyloxy-4,4-diethoxy-L-proline ethyl ester is obtained as a yellow oil.

OISLAND

DK 159115BDK 159115B

18 b) N-Carbobenzyloxy-4,4-diethoxy-L-prolinB) N-Carbobenzyloxy-4,4-diethoxy-L-proline

Den rå ester fra del (a) (10,8 g, 0,03 mol) hydrolyseres med 70 ml IN natriumhydroxid som anført i eksempel 4(b), der tilsættes 30 ml ethanol i 10 ml portioner, hvorved 5 der fås en opløsning, som giver 10,5 g gul viskos olie. Denne olie opløses i 100 ml ether og behandles med 3,0 g cyclo-hexylamin. Ved podning og gnidning udskilles 8,3 g af det krystallinske N-carbobenzyloxy-4,4-diethoxy-L-prolin-cyclo-hexylaminsalt, smeltepunkt 123-126°C (begynder 114°C) , [a]^ 10 -32° (c, 1% i ethanol). Dette materiale omkrystalliseres ud fra 20 ml acetonitril, hvilket giver 7,0 g af saltet som et farveløst fast stof, smeltepunkt 125-128°C (begynder ved 115°C) , [ct]^6 -31° (c, 1% i ethanol).The crude ester of part (a) (10.8 g, 0.03 mol) is hydrolyzed with 70 ml of 1 N sodium hydroxide as set forth in Example 4 (b), to 30 ml of ethanol in 10 ml aliquots to give a solution , which gives 10.5 g of yellow viscous oil. This oil is dissolved in 100 ml of ether and treated with 3.0 g of cyclohexylamine. Upon grafting and rubbing, 8.3 g of the crystalline N-carbobenzyloxy-4,4-diethoxy-L-proline-cyclohexylamine salt is separated, m.p. 123-126 ° C (beginning 114 ° C), [α] 10 -32 ° (c, 1% in ethanol). This material is recrystallized from 20 ml of acetonitrile to give 7.0 g of the salt as a colorless solid, m.p. 125-128 ° C (starts at 115 ° C), [ct] +6 -31 ° (c, 1% in ethanol).

N-Carbobenzyloxy-4,4-diethoxy -L-prolin-cyclohexyl-15 aminsaltet suspenderes i 40 ml ethylacetat, omrøres og behandles med 20 ml IN saltsyre. Lagene adskilles, og den vandige fase ekstraheres med yderligere 3 x 40 ml ethylacetat, de organiske lag forenes, tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 5,6 g (56%) N-carbobenzyloxy-4,4-20 -diethoxy-L-prolin som en lysegul olie.The N-Carbobenzyloxy-4,4-diethoxy-L-proline-cyclohexyl-amine salt is suspended in 40 ml of ethyl acetate, stirred and treated with 20 ml of 1N hydrochloric acid. The layers are separated and the aqueous phase is extracted with an additional 3 x 40 ml of ethyl acetate, the organic layers are combined, dried (MgSO 4) and the solvent is evaporated to give 5.6 g (56%) of N-carbobenzyloxy-4.4-20 -diethoxy-L-proline as a pale yellow oil.

c) 4,4-Diethoxy-L-prolinc) 4,4-Diethoxy-L-proline

En opløsning af de 5,6 g N-carbobenzyloxy-4,4-di-ethoxy-L-prolin (0,017 mol) i 180 ml 2:1 ethanol/vand behandles med 2 g af en 5% palladium-carbon-katalysator og rystes 25 under 3 atm. hydrogen i 6 timer. Det rå delvis faste produkt gnides først under ethanol, derefter ether, og inddampningen gentages hver gang, hvilket giver 3 g (91%) næsten farveløst fast 4,4-diethoxy-L-prolin, smeltepunkt 172-174°C (sønderde- 2 6 ling) med forudgående gradvis mørkfarvning og sintring, [a] ^ 30 -40° (c, 1% i methanol).A solution of the 5.6 g of N-carbobenzyloxy-4,4-di-ethoxy-L-proline (0.017 mol) in 180 ml of 2: 1 ethanol / water is treated with 2 g of a 5% palladium carbon catalyst and shaking 25 below 3 atm. hydrogen for 6 hours. The crude partially solid product is first rubbed under ethanol, then ether, and the evaporation is repeated each time to give 3 g (91%) of almost colorless solid 4,4-diethoxy-L-proline, mp 172-174 ° C (dec. 6 ling) with prior gradual dark staining and sintering, [α] D 30 -40 ° (c, 1% in methanol).

Analyse, beregnet for CgH^NO^*0,25 E^O: C 52,03, H 8,49, N 6,74.Analysis calculated for C CHH NO NONO · 0.25 E₂O: C 52.03, H 8.49, N 6.74.

Fundet: C 52,22, H 8,59, N 6,69.Found: C, 52.22; H, 8.59; N, 6.69.

35 d) (S)-1-[3-(Acetylthio)-2-methyl-1-oxopropy1]-4,4-diethoxy--L-prolin 2,9 g 4,4-diethoxy-L-prolin (0,014 mol) fra del (c)D) (S) -1- [3- (Acetylthio) -2-methyl-1-oxopropyl] -4,4-diethoxy - L-proline 2.9 g 4,4-diethoxy-L-proline (0.014 mol) from part (c)

OISLAND

DK 159115BDK 159115B

19 og 3 g (0,017 mol) D-3-acetylthio-2-methylpropionylchlorid opløst i 3,5 ml ether omsættes i 35 ml vand i nærværelse af natriumcarbonat som anført i eksempel 3(d), hvilket giver 5,4 g svagt gul viskos olie. Dette olieagtige produkt behand-5 les i 40 ml ethylacetat med 2,6 g dicyclohexylamin og fortyndes med 60 ml hexan, hvilket i to udbytter giver 4,9 g (S)--1-[(3-acetylthio)-2-methyl-l-oxopropyl]-4,4-diethoxy-L-pro-lin-dicyclohexylaminsalt, smeltepunkt 135-138°C (begynder ved 132°C). Efter omkrystallisation ud fra 15 ml varm ethyl-10 acetat og 45 ml hexan vejer det farveløse faste salt 4,2 g, smeltepunkt 138-140°C (begynder ved 135°C) , [a]^ -63° (c, 1% i ethanol).19 and 3 g (0.017 mol) of D-3-acetylthio-2-methylpropionyl chloride dissolved in 3.5 ml of ether are reacted in 35 ml of water in the presence of sodium carbonate as indicated in Example 3 (d) to give 5.4 g of pale yellow viscous oil. This oily product is treated in 40 ml of ethyl acetate with 2.6 g of dicyclohexylamine and diluted with 60 ml of hexane to give 4.9 g of (S) - 1 - [(3-acetylthio) -2-methyl in two yields. -1-oxopropyl] -4,4-diethoxy-L-proline dicyclohexylamine salt, mp 135-138 ° C (starts at 132 ° C). After recrystallization from 15 ml of hot ethyl acetate and 45 ml of hexane, the colorless solid salt weighs 4.2 g, m.p. 138-140 ° C (starts at 135 ° C), [α] 25 -63 ° (c, 1 % in ethanol).

Analyse, beregnet for C^2H23^: C 61,33, H 9,15, N 5,30, S 6,06.Analysis calculated for C 21 H 23 O: C 61.33, H 9.15, N 5.30, S 6.06.

15 Fundet: C 61,48, H 9,55, N 5,25, S 5,91.Found: C, 61.48; H, 9.55; N, 5.25; S, 5.91.

Dicyclohexylaminsaltet omdannes til den frie syre ved at suspendere 4,2 g i 40 ml ethylacetat, afkøle og behandle med 40 ml 10% kaliumbisulfatopløsning, hvorved der fås to lag. Efter adskillelse ekstraheres den vandige fase 20 med 3 x 50 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 3,0 g (61%) (S)-1-[3-(acetylthio)-2-methyl-l-oxopropyl]-4,4-dieth-oxy-L-prolin som en bleggul viskos sirup.The dicyclohexylamine salt is converted to the free acid by suspending 4.2 g in 40 ml of ethyl acetate, cooling and treating with 40 ml of 10% potassium bisulfate solution to give two layers. After separation, the aqueous phase 20 is extracted with 3 x 50 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated to give 3.0 g (61%) of (S) -1- [3- (acetylthio) 2-methyl-1-oxopropyl] -4,4-diethoxy-L-proline as a pale yellow viscous syrup.

25 Eksempel 6 (S)-4,4-Diethoxy-l-(3-Mercapto-2-methyl-l-oxopropyl)-L-prolin Argon ledes gennem en kold opoøsning af 5,5 ml koncentreret ammoniumhydroxid i 13 ml vand i 0,25 time. Dette sættes derefter under afkøling under argontæppe til 3,0 g 30 (0,0086 mol) (S)-1-[3-(acetylthio)-2-methyl-l-oxopropyl]-4,4- -diethoxy-L-prolin, og blandingen oparbejdes som beskrevet i eksempel 4, hvilket giver 2,4 g (92%) (S)-4,4-diethoxy-l-(3- -mercapto-2-methyl-l-oxopropyl)-L-prolin som en næsten farve-26 o løs sirup [a]^ -64 , (c, 1% i ethanol).Example 6 (S) -4,4-Diethoxy-1- (3-Mercapto-2-methyl-1-oxopropyl) -L-proline Argon is passed through a cold solution of 5.5 ml of concentrated ammonium hydroxide in 13 ml of water. 0.25 hour. This is then added under cooling under argon blanket to 3.0 g of (0.0086 mol) (S) -1- [3- (acetylthio) -2-methyl-1-oxopropyl] -4,4- diethoxy-L- proline, and the mixture is worked up as described in Example 4 to give 2.4 g (92%) of (S) -4,4-diethoxy-1- (3- mercapto-2-methyl-1-oxopropyl) -L- proline as an almost color-26 o loose syrup [a] + -64, (c, 1% in ethanol).

35 Analyse, beregnet for ci3H23N05 * 0/25 H20: C 50,38, H 7,64, N 4,52, S 10,35.Analysis calculated for C 13 H 23 NO 5 * 0/25 H 2 O: C 50.38, H 7.64, N 4.52, S 10.35.

Fundet: C 50,68, H 7,96, N 4,78, S 10,07.Found: C 50.68, H 7.96, N 4.78, S 10.07.

00

DK 159115 BDK 159115 B

2020

Eksempel 7 [2(S) ,3S] -2-[3-(Acetylthio)-2-methyl-l-oxopropyl3-6,10-dioxa--2-azaspiro[4,5]decan-3-carboxylsyre a) N-Carbobenzyloxy-4,4-trimethylendioxy-L-prolin 5 Omsætning af 8,2 g (0,031 mol) N-carbobenzyloxy- -4-keto-L-prolin og 45 ml (0,62 mol) 1,3-propandiol i 450 ml benzen i nærværelse af 500 mg p-toluensulfonsyre giver 12,3 g råt viskost esterprodukt. Dette produkt hydrolyseres med 70 ml IN natriumhydroxid, hvilket giver 10,6 g rå N-carbo-10 benzyloxy-4,4-trimethylendioxy-L-prolin som en gul olie.Example 7 [2 (S), 3S] -2- [3- (Acetylthio) -2-methyl-1-oxopropyl3-6,10-dioxa-2-azaspiro [4,5] decane-3-carboxylic acid a) N-Carbobenzyloxy-4,4-trimethylenedioxy-L-proline Reaction of 8.2 g (0.031 mol) of N-carbobenzyloxy--4-keto-L-proline and 45 ml (0.62 mol) of 1,3-propanediol in 450 ml of benzene in the presence of 500 mg of p-toluenesulfonic acid gives 12.3 g of raw viscous ester product. This product is hydrolyzed with 70 ml of 1 N sodium hydroxide to give 10.6 g of crude N-carbo-10 benzyloxy-4,4-trimethylenedioxy-L-proline as a yellow oil.

Denne opløses i 40 ml ethanol/400 ml ether og behandles med 3,2 g cyclohexylamin, hvilket giver 10,1 g N-carbobenzyloxy--4,4-trimethylendioxy-L-prolin-cyclohexylaminsalt, smeltepunkt 163-165°C (begynder 160°C, [a]^* -27° (c, 1% i ethanol). 15 Krystallisation af 9,8 g af saltet ud fra 300 ml acetonitril giver 9,5 g farveløst fast cyclohexylaminsalt, smeltepunkt 165-167°C (begynder 162°C), [a]^5 -27° (c, 1% i ethanol).This is dissolved in 40 ml of ethanol / 400 ml of ether and treated with 3.2 g of cyclohexylamine to give 10.1 g of N-carbobenzyloxy - 4,4-trimethylenedioxy-L-proline-cyclohexylamine salt, mp 163-165 ° C Crystallization of 9.8 g of the salt from 300 ml of acetonitrile gives 9.5 g of colorless solid cyclohexylamine salt, mp 165-167 ° C (beginning 162 ° C), [α] 25 D -27 ° (c, 1% in ethanol).

Cyclohexylaminsaltet (9,0 g) suspenderes i 40 ml ethylacetat, omrøres, afkøles og behandles med 45 ml IN salt-20 syre. Lagene adskilles, den vandige fase ekstraheres med yderligere 3 x 40 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 7,1 g (75%) glaslignende N-carbobenzyloxy-4,4-trimethylendi-oxy-L-prolin.The cyclohexylamine salt (9.0 g) is suspended in 40 ml of ethyl acetate, stirred, cooled and treated with 45 ml of 1N hydrochloric acid. The layers are separated, the aqueous phase is extracted with an additional 3 x 40 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated to give 7.1 g (75%) of glass-like N-carbobenzyloxy-4,4-trimethylene di oxy-L-proline.

25 b) 4,4-Trimethylendioxy-L-prolinB) 4,4-trimethylenedioxy-L-proline

En opløsning af 7,1 g (0,022 mol) N-carbobenzyl- oxy-4,4-trimethylendioxy-L-prolin i 200 ml 2:1 methanol/vand hydrogeneres i nærværelse af 2 g 5% palladium-carbon-kataly- sator, hvilket giver 3,8 g (93%) næsten farveløs 4,4-trimethyl- 30 endioxy-L-prolin, smeltepunkt 234-236°C (sønderdeling) med 25 o forudgående gradvis mørkfarvning of sintring, [α] β -36 (c, 1% i 1:1 methanol/vand).A solution of 7.1 g (0.022 mol) of N-carbobenzyloxy-4,4-trimethylenedioxy-L-proline in 200 ml of 2: 1 methanol / water is hydrogenated in the presence of 2 g of 5% palladium carbon catalyst. , giving 3.8 g (93%) of almost colorless 4,4-trimethylenedioxy-L-proline, m.p. 234-236 ° C (dec.) with 25 degrees of gradual darkening of sintering, [α] β -36 (c, 1% in 1: 1 methanol / water).

Analyse, beregnet for C 51,33, H 7,00, N 7,48, 35 Fundet: C 51,42, H 7,11, N 7,40.Analysis calculated for C, 51.33; H, 7.00; N, 7.48; Found: C, 51.42; H, 7.11; N, 7.40.

OISLAND

DK 159115BDK 159115B

21 c) [2(S),3S]-2-[3-(Acetylthio)-2-methyl-l-oxopropyl]-6,10-di-oxa-2-azaspiro[4,5]decan-3-carboxylsyre 3,7 g (0,02 mol) 4,4-trimethylendioxy-L-prolin acy-leres med 4,0 g (0,022 mol) D-3-acetylthio-2-methylpropionyl-5 chlorid i 50 ml vand i nærværelse af natriumcarbonat som anført i eksempel 1(e), hvilket giver 7,3 g glaslignende råprodukt.C) [2 (S), 3S] -2- [3- (Acetylthio) -2-methyl-1-oxopropyl] -6,10-dioxa-2-azaspiro [4,5] decane-3 Carboxylic acid 3.7 g (0.02 mole) of 4,4-trimethylenedioxy-L-proline is acylated with 4.0 g (0.022 mole) of D-3-acetylthio-2-methylpropionyl chloride in 50 ml of water in the presence of sodium carbonate as set forth in Example 1 (e) to give 7.3 g of glass-like crude product.

Produktet omdannes til dicyclohexylaminsaltet med 3,6 g dicyclohexylamin i 70 ml ethylacetat. Efter podning 10 og gnidning udfældes det krystallinske salt, smeltepunkt 168-170°C (begynder 166°C) , [a]^* -59° (c,l% i ethanol). Omkrystallisation ud fra 30 ml acetonitril giver 6,5 g farveløst fast salt, smeltepunkt 169-171°, [a]^ -63°, (c, 1% i ethanol).The product is converted to the dicyclohexylamine salt with 3.6 g of dicyclohexylamine in 70 ml of ethyl acetate. After grafting 10 and rubbing, the crystalline salt, m.p. 168-170 ° C (starts 166 ° C), [α] D -59 ° (c, 1% in ethanol). Recrystallization from 30 ml of acetonitrile gives 6.5 g of colorless solid salt, m.p. 169-171 °, [α] D -63 °, (c, 1% in ethanol).

15 Dicyclohexylaminsaltet omdannes til den frie syre ved,at man suspenderer 6,4 g i 75 ml ethylacetat og behandler med 75 ml 10% kaliumbisulfat og omrører, indtil der fås to lag. Efter adskillelse ekstraheres den vandige fase med ethylacetat (4 x 75 ml), de organiske lag forenes, tørres (MgS04) 20 og opløsningsmidlet afdampes, hvilket giver 4,3 g (67%) glaslignende [2(S),3S]-2-[3-(acetylthio)-2-methyl-l-oxopropyl]--6,10-dioxa-2-azaspiro[4,5]decan-3-carboxylsyre.The dicyclohexylamine salt is converted to the free acid by suspending 6.4 g in 75 ml of ethyl acetate and treating with 75 ml of 10% potassium bisulfate and stirring until two layers are obtained. After separation, the aqueous phase is extracted with ethyl acetate (4 x 75 mL), the organic layers are combined, dried (MgSO 4) and the solvent evaporated to give 4.3 g (67%) of glass-like [2 (S), 3S] -2 - [3- (acetylthio) -2-methyl-l-oxopropyl] - 6,10-dioxa-2-azaspiro [4.5] decane-3-carboxylic acid.

Eksempel 8 25 [2(S),3S]-2-(3-Mercapto-2-methyl-l-oxopropyl)-6,lQ-dioxa-2- -azaspiro[4,5]decan-3-carboxylsyre [2(S),3S]-2-[3-(Acetylthio)-2-methyl-l-oxopropyl]- -6,10-dioxo-2-azaspiro[4,5]dican-3-carboxylsyre (4,3 g, 0,013 mol) hydrolyseres med 8,5 ml koncentreret ammoniak i 20 ml 30 ifølge fremgangsmåden i eksempel 2, hvilket giver 0,9 g far- 25 o veløst fast produkt, [a] -64 (c, 0,5% i ethanol). Der fås yderligere 0,8 g produkt ved at ekstrahere den vandige 25 o fase med chloroform, [α] -66 . De to udbytter opløses i chloroform, inddampes, gnides under ether, og inddampningen 35 gentages, hvilket giver 1,7 g (46%) [2(S),3S]-2-(3-mercapto- -2-methyl-l-oxopropyl)-6,10-dioxo-2-azaspiro[4,5]decan-3--carboxylsyre, smeltepunkt 169-171° (begynder 167°), [a]^ 22Example 8 [2 (S), 3S] -2- (3-Mercapto-2-methyl-1-oxopropyl) -6,1-dioxa-2-azaspiro [4,5] decane-3-carboxylic acid [2 (S), 3S] -2- [3- (Acetylthio) -2-methyl-1-oxopropyl] -6,10-dioxo-2-azaspiro [4,5] dican-3-carboxylic acid (4.3 g (0.013 mol) is hydrolyzed with 8.5 ml of concentrated ammonia in 20 ml of the procedure of Example 2 to give 0.9 g of colorless volatile solid, [a] -64 (c, 0.5% in ethanol). ). An additional 0.8 g of product is obtained by extracting the aqueous phase with chloroform, [α] -66. The two yields are dissolved in chloroform, evaporated, rubbed under ether and the evaporation 35 repeated, yielding 1.7 g (46%) of [2 (S), 3S] -2- (3-mercapto-2-methyl-1 -oxopropyl) -6,10-dioxo-2-azaspiro [4,5] decane-3-carboxylic acid, m.p. 169-171 ° (beginning 167 °), [α] 22

OISLAND

DK 159115 BDK 159115 B

-71° (c, 1% i methanol).-71 ° (c, 1% in methanol).

Analyse, beregnet for C 49,81, H 6,62, N 4,84, S 11,08.Analysis calculated for C 49.81, H 6.62, N 4.84, S 11.08.

Fundet: C 49,67, H 6,67, N 4,93, S 11,10.Found: C 49.67, H 6.67, N 4.93, S 11.10.

55

Eksempel 9 [7(S),8S]-7-[3-(Acetylthio)-2-methyl-l-oxopropyl]-7-aza-l,4--dithiaspiro[4,4]nonan-8-carboxylsyre a) N-Carbobenzyloxy-4,4-ethylendithio-L-prolin-methylester 10 En omrørt opløsning af 3,9 g (0,014 mol) N-carbo- benzyloxy-4-keto-L-prolin-methylester i 60 ml methylenchlo-rid behandles med 3 ml (0,036 mol) ethandithiol, afkøles til 8°C og behandles under argontæppe med 3 ml (0,024 mol) bor-trifluoridetherat. Efter at kølebadet er fjernet, omrøres 15 den bleggule opløsning i yderligere en time og holdes natten over ved stuetemperatur. Opløsningen omrøres, behandles med flere stykker knust is, efterfulgt af 20 ml vand. Efter 30 minutters forløb skilles lagene, og den vandige fase (50 ml) ekstraheres med yderligere 3 x 30 ml methylenchlorid. De 20 forenede organiske lag vaskes med 50 ml mættet natriumchlorid-opløsning, tørres (MgSO^), og opløsningsmidlet fjernes på en roterende fordamper, hvilket giver 6 g (100%) af en bleggul olie, N-carbobenzyloxy-4,4-ethylendithio-L-prolin-methylester.Example 9 [7 (S), 8S] -7- [3- (Acetylthio) -2-methyl-1-oxopropyl] -7-aza-1,4-dithiaspiro [4,4] nonane-8-carboxylic acid a N-Carbobenzyloxy-4,4-ethylenedithio-L-proline methyl ester A stirred solution of 3.9 g (0.014 mol) of N-carbenzyloxy-4-keto-L-proline methyl ester in 60 ml of methylene chloride treated with 3 ml (0.036 mol) of ethanedithiol, cooled to 8 ° C and treated under argon blanket with 3 ml (0.024 mol) of boron trifluoride etherate. After the cooling bath is removed, the pale yellow solution is stirred for an additional hour and kept overnight at room temperature. The solution is stirred, treated with several pieces of crushed ice, followed by 20 ml of water. After 30 minutes, the layers are separated and the aqueous phase (50 ml) is extracted with an additional 3 x 30 ml of methylene chloride. The 20 combined organic layers are washed with 50 ml of saturated sodium chloride solution, dried (MgSO 4) and the solvent removed on a rotary evaporator to give 6 g (100%) of a pale yellow oil, N-carbobenzyloxy-4,4-ethylenedithio -L-proline methyl ester.

b) N-Carbobenzyloxy-4,4-ethylendithio-L-prolin 25 Methylesterproduktet fra del (a) (7,4 g, ca. 0,018 mol) opløses i 65 ml methanol, behandles dråbevis ved -1 til 4°C med 14,5 ml (0,029 mol) 2N natriumhydroxid, holdes ved 0°C i en time og ved stuetemperatur natten over. Efter at ca. halvdelen af opløsningsmidlet er fjernet på en roterende 30 fordamper, fortyndes opløsningen med 125 ml vand, vaskes med ether (vaskevæsken kasseres), gøres sur under afkøling med 5 ml 1:1 saltsyre til pH 2 og ekstraheres med ethylacetat (4 x 50 ml). De forenede ekstrakter vaskes med 50 ml mættet na-triumchlorid, tørres (MgS04), og opløsningsmidlet afdampes, 35 hvilket giver 6 g af en bleggul viskos olie. Denne olie opløses i 25 ml ethanol, behandles med 1,8 g cyclohexylamin i 5 ml ethanol og fortyndes til 300 ml med ether. Ved podningb) N-Carbobenzyloxy-4,4-ethylenedithio-L-proline The methyl ester product of part (a) (7.4 g, about 0.018 mol) is dissolved in 65 ml of methanol, treated dropwise at -1 to 4 ° C with 14 , 5 ml (0.029 mol) of 2N sodium hydroxide, is kept at 0 ° C for one hour and at room temperature overnight. After approx. half of the solvent was removed on a rotary evaporator, diluted with 125 ml of water, washed with ether (the washing liquid discarded), acidified with cooling with 5 ml of 1: 1 hydrochloric acid to pH 2 and extracted with ethyl acetate (4 x 50 ml). . The combined extracts are washed with 50 ml of saturated sodium chloride, dried (MgSO 4) and the solvent is evaporated to give 6 g of a pale yellow viscous oil. This oil is dissolved in 25 ml of ethanol, treated with 1.8 g of cyclohexylamine in 5 ml of ethanol and diluted to 300 ml with ether. When grafting

OISLAND

DK 159115BDK 159115B

23 og gnidning udskilles det krystallinske cyclohexylaminsalt, hvilket efter køling natten over giver 5,7 g N-carbobenzyloxy--4,4-ethylendithio-L-prolin-cyclohexylaminsalt, smeltepunkt 205-207°C (begynder 201°C). Omkrystallisation ud fra 50 ml 5 ethanol/400 ml ether giver 4,9 g farveløst fast salt, smeltepunkt 207-209°C (begynder 201°C) , [a]^ -15° (c, 1% i chloroform) .23 and rubbing separates the crystalline cyclohexylamine salt to give, after cooling overnight, 5.7 g of N-carbobenzyloxy - 4,4-ethylenedithio-L-proline-cyclohexylamine salt, mp 205-207 ° C (beginning 201 ° C). Recrystallization from 50 ml of ethanol / 400 ml of ether gives 4.9 g of colorless solid salt, m.p. 207-209 ° C (beginning 201 ° C), [.alpha.

Cyclohexylaminsaltet (4,8 g) suspenderes i 25 ml ethylacetat, omrøres og behandles med 25 ml IN saltsyre. Når 10 der fås to klare lag, skilles disse ad, den vandige fase eks-traheres med yderligere 3 x 25 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 3,8 g (62%) N-carbobenzyloxy-4,4-ethylendithio--L-prolin som en bleggul viskos sirup.The cyclohexylamine salt (4.8 g) is suspended in 25 ml of ethyl acetate, stirred and treated with 25 ml of 1N hydrochloric acid. When two clear layers are obtained, these are separated, the aqueous phase is extracted with an additional 3 x 25 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated to give 3.8 g (62%) N-carbobenzyloxy-4,4-ethylenedithio - L-proline as a pale yellow viscous syrup.

15 c) 4,4-Ethylendithio-L-prolin-hydrobromid 3,7 g N-carbobenzyloxy-4,4-ethylendithio-L-prolin (0,011 mol) behandles med 20 ml hydrogenbromid i eddikesyre (30-32%), tilproppes løst og omrøres magnetisk. Blanding er vanskelig på grund af udgangsmaterialets viskositet, og det-20 te opdeles så meget som muligt med en spatel. I mellemtiden begynder det krystallinske produkt at udskilles. Der tilsættes yderligere mængder hydrogenbromid i eddikesyre efter 15 minutter (10 ml) og efter 25 minutter (5 ml) og omrøringen fortsættes i ialt 35 minutter. Der tilsættes 250 ml ether 25 for at afslutte udfældningen af produktet, og efter afkøling i 15 minutter filtreres det cremefarvede materiale under nitrogen, vaskes med ether og tørres i vakuum, hvilket giver 2,7 g 4,4-ethylendithio-L-prolin-hydrobromid, smeltepunkt 240-242°C (sønderdeling), sintring og mørkfarvning fra ca.C) 4,4-Ethylenedithio-L-proline hydrobromide 3.7 g of N-carbobenzyloxy-4,4-ethylenedithio-L-proline (0.011 mol) is treated with 20 ml of hydrogen bromide in acetic acid (30-32%). loosely and magnetically stirred. Mixing is difficult due to the viscosity of the starting material and it is divided as much as possible with a spatula. Meanwhile, the crystalline product begins to secrete. Additional amounts of hydrogen bromide in acetic acid are added after 15 minutes (10 ml) and after 25 minutes (5 ml) and stirring is continued for a total of 35 minutes. 250 ml of ether 25 is added to complete the precipitation of the product and after cooling for 15 minutes the cream colored material is filtered under nitrogen, washed with ether and dried in vacuo to give 2.7 g of 4,4-ethylenedithio-L-proline. hydrobromide, melting point 240-242 ° C (decomposition), sintering and darkening from approx.

30 200°C, [a]^ -40° (c, 0,5% i 1:1 chloroform/methanol) .-20 ° (c, 0.5% in 1: 1 chloroform / methanol).

d) [7(S),8S]-7-[3-(Acetylthio)-2-methyl-l-oxoprQpyl]-7-aza--1,4-dithiaspiro[4,4]nonan-8-carboxylsyred) [7 (S), 8S] -7- [3- (Acetylthio) -2-methyl-1-oxopropyl] -7-aza - 1,4-dithiaspiro [4,4] nonane-8-carboxylic acid

En omrørt opløsning af 2,6 g (0,0091 mol) 4,4-e-thylendithio-L-prolin-hydrobromid i 25 ml vand afkøles til 35 5°C og bringes til pH 8,2 ved tilsætning af 25% natriumcarbo- nat (vægt/volumen). Under fortsat omrøring og afkøling tilsættes portionsvis en opløsning af 1,9 g (0,01 mol) D-3-ace-tylthio-2-methylpropionylchlorid i 2,5 ml ether, idet pH holdes på 7,5-8,2 ved dråbevis tilsætning af 25% natriumcarbo-A stirred solution of 2.6 g (0.0091 mol) of 4,4-e-thylenedithio-L-proline hydrobromide in 25 ml of water is cooled to 35 ° C and brought to pH 8.2 by addition of 25% sodium carbohydrate. - night (weight / volume). With continued stirring and cooling, a solution of 1.9 g (0.01 mole) of D-3-acetylthio-2-methylpropionyl chloride in 2.5 ml of ether is added portionwise, keeping the pH of 7.5-8.2 at dropwise addition of 25% sodium carbonate

OISLAND

DK 159115 BDK 159115 B

24 nat. Når pH er stabiliseret på 8,2-8,5 (efter ca. 15 minutter), fortsættes omrøring og afkøling i ialt en time. Opløsningen vaskes derefter med 25 ml ethylacetat (vaskevæsken kasseres, dækkes med et lag af 25 ml ethylacetat, afkøles, 5 omrøres, gøres forsigtigt sur med 1:1 saltsyre til pH 2,0, mættes med natriumchlorid, og lagene adskilles. Den vandige fase ekstraheres med yderligere ethylacetat (3 x 25 ml), de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, tilsidst ved 0,2 mm, hvilket giver 2,6 g sirups-10 agtigt produkt, der begynder at krystallisere. Dette behandles i 30 ml ethylacetat med 1,5 g dicyclohexylamin, hvilket giver 3,0 g farveløst dicyclohexylaminsalt, smeltepunkt 176-178° (s 170°C) , [a]^6 -55° (c, 1% i ethanol). Dette materiale formales i en morter under 15 ml acetonitril, afkø-15 les i en time, filtreres, vaskes med 5 ml kold acetonitril og med ether og tørres, hvilket giver 2,9 g dicyclohexylaminsalt, smeltepunkt 177-179°C (s 172°), [a]^ -56° (c, 1% i ethanol).24 night. When the pH is stabilized at 8.2-8.5 (after about 15 minutes), stirring and cooling are continued for a total of one hour. The solution is then washed with 25 ml of ethyl acetate (the wash liquid is discarded, covered with a layer of 25 ml of ethyl acetate, cooled, stirred, gently acidified with 1: 1 hydrochloric acid to pH 2.0, saturated with sodium chloride and the layers separated. is extracted with additional ethyl acetate (3 x 25 mL), the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.2 mm to give 2.6 g of syrupy product which begins to crystallize. is treated in 30 ml of ethyl acetate with 1.5 g of dicyclohexylamine to give 3.0 g of colorless dicyclohexylamine salt, mp 176-178 ° (s 170 ° C), [α] 6 -55 ° (c, 1% in ethanol). This material is ground in a mortar under 15 ml of acetonitrile, cooled for one hour, filtered, washed with 5 ml of cold acetonitrile and with ether and dried to give 2.9 g of dicyclohexylamine salt, mp 177-179 ° C (p 172 °), [α] 25 -56 (c, 1% in ethanol).

Analyse, beregnet for ci3HigN04S’c;L2H23N: 20 C 56,56, H 7,98, N 5,28, S 18,12.Calcd for C 13 HigNO 4 S; L 2 H 23 N: 20 C 56.56, H 7.98, N 5.28, S 18.12.

Fundet: C 56,21, H 8,18, N 5,05, S 18,00.Found: C 56.21, H 8.18, N 5.05, S 18.00.

Det ovennævnte dicyclohexylaminsalt omdannes til den frie syre ved at suspendere 2,8 g i 30 ml ethylacetat, afkøles og behandle med 30 ml 10% kaliumbisulfat, hvilket 25 giver to klare lag. Efter adskillelse ekstraheres den vandige fase med 3 x 50 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, til sidst ved 0,1-0,2 mm og 45°C, hvilket giver 2,0 g (63%) farveløs fast [7(S),8S]-7-[3-(acetylthio)-2-methyl-l-oxopropyl]-7-30 -aza-l,4-dithiaspiro[4,4]-nonan-8-carboxylsyre, smeltepunkt 125-126°C (s, 122°C) , [a]^6 -101° (c, 1% i ethanol).The above dicyclohexylamine salt is converted to the free acid by suspending 2.8 g in 30 ml of ethyl acetate, cooled and treated with 30 ml of 10% potassium bisulfate to give two clear layers. After separation, the aqueous phase is extracted with 3 x 50 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.1-0.2 mm and 45 ° C to give 2.0 g ( 63%) colorless solid [7 (S), 8S] -7- [3- (acetylthio) -2-methyl-1-oxopropyl] -7-30 -aza-1,4-dithiaspiro [4,4] nonane -8-carboxylic acid, m.p. 125-126 ° C (s, 122 ° C), [α] 6 -101 ° (c, 1% in ethanol).

Eksempel 10 [7 (S) , 8S3-7-(3-Mercapto-2-methyl-l-oxopropyl)-7-aza-l,4-di-35 thiaspiro[4,4]nonan-8-carboxylsyreExample 10 [7 (S), 8S3-7- (3-Mercapto-2-methyl-1-oxopropyl) -7-aza-1,4-di-thiazpiro [4,4] nonane-8-carboxylic acid

Argon ledes gennem en kold opløsning af 3,5 ml koncentreret ammoniak i 8,5 ml vand i 15 minutter. Dette til-Argon is passed through a cold solution of 3.5 ml of concentrated ammonia in 8.5 ml of water for 15 minutes. This adds

OISLAND

DK 159115 BDK 159115 B

25 sættes derefter under afkøling og argontæppe til 1,9 g (0,054 mol) [7(S),8S]-7-[3-(acetylthio)-2-methyl-l-oxopropyl]-7-aza--l,4-dithiaspiro[4,4]nonån-8-carboxylsyre, og blandingen hvirvles rundt i isbad, indtil der fås en opløsning. Omrø-5 ring under argon fortsættes ved stuetemperatur i yderligere to timer, derefter ekstraheres opløsningen med 15 ml ethyl-acetat under argonatmosfære. Det vandige lag afkøles, omrøres, dækkes med et lag af 15 ml ethylacetat og gøres portionsvis sure med ca. 6,5 ml 1:1 saltsyre. Lagene adskilles, den 10 vandige fase ekstraheres med yderligere 3 x 15 ml ethylacetat, de forenede acetatlag tørres (I»lgS04), og opløsningsmidlet afdampes, hvilket giver en glaslignende remanens, der størkner, når den gnides under ether. Afdampningen gentages, og det farveløse produkt suspenderes i 30 ml hexan, fil-15 treres og tørres i vakuum, hvilket giver 1,4 g (84%) [7(S), 8S]— 7—(3-mercapto-2-methyl-l-oxopropyl)-7-aza-l,4-dithiaspi-ro[4,4]nonan-8-carboxylsyre, smeltepunkt 116-118°C (s 105°C), [a]p® -44° (c, 1% i ethanol).25 is then added under cooling and argon blanket to 1.9 g (0.054 mol) [7 (S), 8S] -7- [3- (acetylthio) -2-methyl-1-oxopropyl] -7-aza-1, 4-dithiaspiro [4,4] non-8-carboxylic acid and the mixture is swirled in an ice bath until a solution is obtained. Stirring under argon is continued at room temperature for an additional two hours, then the solution is extracted with 15 ml of ethyl acetate under argon atmosphere. The aqueous layer is cooled, stirred, covered with a layer of 15 ml of ethyl acetate and made portionwise acidic with ca. 6.5 ml of 1: 1 hydrochloric acid. The layers are separated, the aqueous phase is extracted with an additional 3 x 15 ml of ethyl acetate, the combined acetate layers are dried (µgSO 4) and the solvent is evaporated to give a glass-like residue which solidifies as rubbed under ether. Evaporation is repeated and the colorless product is suspended in 30 ml of hexane, filtered and dried in vacuo to give 1.4 g (84%) [7 (S), 8S] - 7- (3-mercapto-2 methyl-1-oxopropyl) -7-aza-1,4-dithiaspiro [4,4] nonane-8-carboxylic acid, m.p. 116-118 ° C (s 105 ° C), [a] p® -44 ° (c, 1% in ethanol).

Analyse, beregnet for C^H^NO^S^: 20 C 42,97, H 5,57, N 4,56, S 31,29, SH 100%Analysis calculated for C CH ^ NONO SS: 20 C 42.97, H 5.57, N 4.56, S 31.29, SH 100%

Fundet: C 42,70, H 5,71, N 4,54, S 31,13, SH 100%.Found: C 42.70, H 5.71, N 4.54, S 31.13, SH 100%.

Eksempel 11Example 11

(8S)-7-[3-(Acetylthio)-2-trifluormethyl-l-oxopropyl]-1,4-di-25 oxa-7-azaspiro[4,4]nonan-8-carboxylsyre, isomere A og B(8S) -7- [3- (Acetylthio) -2-trifluoromethyl-1-oxopropyl] -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid, isomers A and B

a) D,L-3-(Acetylthio)-2-trifluormethylpropionsyre 10 g (0,071 mol) α-trifluormethylacrylsyre, fremstillet som anført i J.Chem.Soc., 1954, side 371, afkøles i et bad af is, vand og salt, omrøres og behandles portions-30 vis med 5,7 ml (0,075 mol) 97% thioleddikesyre. Efter tilsætningen omrøres en gule væske i kulden i en time, får lov at varme op til stuetemperatur og destilleres, hvilket giver 14 g (91%) D,L-3-(acetylthio)-2-trifluormethylpropionsyre som en lysegul olie, kogepunkt 149-153°C/13 mm. Materialet størk-35 ner ved opbevaring i kulden.a) D, L-3- (Acetylthio) -2-trifluoromethylpropionic acid 10 g (0.071 mol) of α-trifluoromethylacrylic acid, prepared as set forth in J.Chem.Soc., 1954, page 371, is cooled in a bath of ice, water and salt, stirred and treated portionwise with 5.7 ml (0.075 mol) of 97% thiolacetic acid. After the addition, a yellow liquid is stirred in the cold for one hour, allowed to warm to room temperature and distilled to give 14 g (91%) of D, L-3- (acetylthio) -2-trifluoromethylpropionic acid as a pale yellow oil, boiling point 149 -153 ° C / 13 mm. The material solidifies when stored in the cold.

2626

OISLAND

DK 159115 BDK 159115 B

b) D,L-3~(Acetylthio)-2-trifluormethylpropionylchlorid 7 g (0,032 mol) D,L-3-(acetylthio)-2-trifluorme-thylpropionylsyre behandles med 18 ml (0,25) redestilleret thionylchlorid, og blandingen tilbagesvales i tre timer. Ef-5 ter at det overskydende thionylchlorid er fjernet på en roterende fordamper, destilleres remanensen, hvilket giver 6,8 g D,L-3-(acetylthio)-2-trifluormethylpropionylchlorid som en bleggul olie, kogepunkt 80-82°C/16 mm.b) D, L-3 ~ (Acetylthio) -2-trifluoromethylpropionyl chloride 7 g (0.032 mol) of D, L-3- (acetylthio) -2-trifluoromethylpropionyl acid are treated with 18 ml (0.25) of redistilled thionyl chloride and the mixture reflux for three hours. After the excess thionyl chloride is removed on a rotary evaporator, the residue is distilled to give 6.8 g of D, L-3- (acetylthio) -2-trifluoromethylpropionyl chloride as a pale yellow oil, boiling point 80-82 ° C / 16 mm.

c) (8S)-7-[3-(Acetylthio)-2-trifluormethyl-l-oxopropyl]-1,4- 10 -dioxa-7-azaspiro[4,4]nonan-8-carboxylsyre (isomere A og B) 2,4 g (0,014 mol) 4,4-ethylendioxy-L-prolin omsættes med 3,4 g (0,014 mol) D,L-3-(acetylthio)-2-trifluormethylpropionylchlorid i 40 ml vand i nærværelse af natriumcarbo-nat ifølge fremgangsmåden i eksempel 1(e), hvilket giver 4,5 15 g næsten farveløst fast produkt, smeltepunkt 126-145°C (s 115°C) , [cx]2d5 -34° (c, 1% i ethanol).c) (8S) -7- [3- (Acetylthio) -2-trifluoromethyl-1-oxopropyl] -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid (isomers A and B ) 2.4 g (0.014 mol) of 4,4-ethylenedioxy-L-proline is reacted with 3.4 g (0.014 mol) of D, L-3- (acetylthio) -2-trifluoromethylpropionyl chloride in 40 ml of water in the presence of sodium carbonate. overnight according to the procedure of Example 1 (e) to give 4.5 15 g of almost colorless solid product, mp 126-145 ° C (s 115 ° C), [cx] 2d5 -34 ° (c, 1% in ethanol) .

Blandingen af diastereoisomere (4,2 g) suspenderes i 45 ml ether, omrøres i to timer, afkøles i 20 minutter, og det uopløste faste stof filtreres, vaskes med kold ether ogThe mixture of diastereoisomers (4.2 g) is suspended in 45 ml of ether, stirred for two hours, cooled for 20 minutes and the undissolved solid is filtered, washed with cold ether and dried.

20 lufttørres, hvilket giver 2,7 g produkt, smeltepunkt 166-172°C20 is air dried to give 2.7 g of product, mp 166-172 ° C

(s 140°C), [a]^ -62° (c, 1% i ethanol). Materialet formales derefter i en morter under 25 ml ether, filtreres efter 15 minutter, vaskes med noget ether og lufttørres igen, hvilket giver 2,1 g produkt, (smeltepunkt 172-177°C (s 143°C). Efter 25 krystallisation ud fra 11 ml kogende isopropanol og afkøling natten over fås 1,55 g farveløs (8S)-7-[3-(acetylthio)-2-tri- fluormethyl-l-oxopropyl]-1,4-dioxa-7-azaspiro[4,4]nonan-8- -carboxylsyre, isomer A, smeltepunkt 192-194°C, (s 183°C), 25 o [a] -32 (c, 1% i ethanol). En prøve omkrystalliseres U . o c 30 ud fra isopropanol, smeltepunkt 193-195°C (s 184°C) , [a]^ -134° (c, 1% i ethanol).(s 140 ° C), [α] D -62 ° (c, 1% in ethanol). The material is then ground in a mortar under 25 ml of ether, filtered after 15 minutes, washed with some ether and air dried again to give 2.1 g of product, (mp 172-177 ° C (s 143 ° C). from 11 ml of boiling isopropanol and cooling overnight, 1.55 g of colorless (8S) -7- [3- (acetylthio) -2-trifluoromethyl-1-oxopropyl] -1,4-dioxa-7-azaspiro [4 , 4] nonan-8-carboxylic acid, isomer A, m.p. 192-194 ° C, (s 183 ° C), 25 o [a] -32 (c, 1% in ethanol). from isopropanol, mp 193-195 ° C (s 184 ° C), [α] D -134 ° (c, 1% in ethanol).

Isomer B fås ved at kombinere ovenstående ether-og isopropanolfiltrater og fjerne opløsningsmidlerne under formindsket tryk, hvilket giver 2,2 g af et svagt gult fast 35 stof, smeltepunkt 108-109°C (s 95°C) , [a]^ +30° (c, 1% i ethanol). Dette materiale renses ved krystallisation udIsomer B is obtained by combining the above ether and isopropanol filtrates and removing the solvents under reduced pressure to give 2.2 g of a pale yellow solid, mp 108-109 ° C (s 95 ° C), [a] + 30 ° (c, 1% in ethanol). This material is purified by crystallization

OISLAND

DK 159115BDK 159115B

27 fra 6 ml isopropanol, hvilket giver 1,2 g næsten farveløst fast stof, smeltepunkt 153-155°C (s 130°C), [a]^ +40° (c, 1% i ethanol). Efter krystallisation ud fra 4 ml ethylace-tat/6 ml hexan fås 1,1 g (8S)-7-[3-(acetylthio)-2-trifluor-5 methyl-l-oxopropyl]-1,4-dioxa-7-azaspiro[4,4]nonan-8-carboxylsyre, isomer B, smeltepunkt 153-155°C (s 141°), [a]^ +41° (c, 1% i ethanol).27 from 6 ml of isopropanol to give 1.2 g of almost colorless solid, mp 153-155 ° C (s 130 ° C), [α] + 40 ° (c, 1% in ethanol). After crystallization from 4 ml of ethyl acetate / 6 ml of hexane, 1.1 g of (8S) -7- [3- (acetylthio) -2-trifluoro-5-methyl-1-oxopropyl] -1,4-dioxa-7 is obtained. -azaspiro [4,4] nonan-8-carboxylic acid, isomer B, mp 153-155 ° C (s 141 °), [α] + 41 ° (c, 1% in ethanol).

Eksempel 12 1 q (8S)-7-(3-Mercapto-2-trifluormethyl-l-oxopropyl)-1,4-dioxa-7-Example 12 1 q (8S) -7- (3-Mercapto-2-trifluoromethyl-1-oxopropyl) -1,4-dioxa-7-

-azaspiro[4,4]nonan-8-carboxylsyre-isomer A-azaspiro [4,4] nonane-8-carboxylic acid isomer A

Isomer A-produktet fra eksempel 16 (1,45 g, 0,0039 mol) hydrolyseres med 2,5 ml koncentreret ammoniak i 6 ml vand i en time som beskrevet i eksempel 2, hvilket giver 15 1,25 g (97%) farveløs (8S)-7-(3-mercapto-2-trifluormethyl-1- -oxopropyl)-1,4-dioxo-7-azaspiro[4,4]nonan-8-carboxylsyre, 25 o isomer A, som et glaslignende produkt, [a] -61 (c, 1% i ethanol). TLC: Rf 0,40 (95:5:5 methylenchlorid/methanol/ed-dikesyre, vis. SH-reagens, PMA og varme).The isomer A product of Example 16 (1.45 g, 0.0039 mol) is hydrolyzed with 2.5 ml of concentrated ammonia in 6 ml of water for one hour as described in Example 2 to give 1.25 g (97%) colorless (8S) -7- (3-mercapto-2-trifluoromethyl-1-oxopropyl) -1,4-dioxo-7-azaspiro [4,4] nonane-8-carboxylic acid, 25 isomer A, as a glass-like product, [α] -61 (c, 1% in ethanol). TLC: Rf 0.40 (95: 5: 5 methylene chloride / methanol / acetic acid, vis. SH reagent, PMA and heat).

20 Analyse, beregnet for C11H14F3N05S: C 40,12, H 4,28, N 4,25, S 9,74, F 17,31. Fundet: C 40,10, H 4,43, N 4,51, S 9,63, F 17,10. Ovennævnte syre opløses i ethylacetat og behandles med 1-adamantanamin, hvilket giver 1-adamantanaminsaltet, smel-25 tepunkt 213-125° (sønderdeling, [a]^* -47° (c, 1% i methanol).Analysis calculated for C 11 H 14 F 3 NO 5 S: C 40.12, H 4.28, N 4.25, S 9.74, F 17.31. Found: C 40.10, H 4.43, N 4.51, S 9.63, F 17.10. The above acid is dissolved in ethyl acetate and treated with 1-adamantanamine to give the 1-adamantanamine salt, mp 213-125 ° (dec., [A] + - 47 ° (c, 1% in methanol).

Eksempel 13 (8S)-7-(3-Mercapto-2-trifluormethyl-l-oxopropyl)-1,4-dioxa-Example 13 (8S) -7- (3-Mercapto-2-trifluoromethyl-1-oxopropyl) -1,4-dioxide

-7-azaspiro[4,4]nonan-8-carboxylsyre, isomer B-7-azaspiro [4,4] nonane-8-carboxylic acid, isomer B

3Q Isomer B-produktet fra eksempel 16 (1,05 g, 0,028 mol) hydrolyseres med 2 ml koncentreret ammoniak i 5 ml vand ifølge fremgangsmåden i eksempel 2, hvilket giver 0,9 g (97%) (8S)-7-(3-mercapto-2-trifluormethyl-l-oxopropyl)-l,4- -dioxa-7-azaspiro[4,4]nonan-8-carboxylsyre, isomer B som 2 5 35 en svagt gul viskos sirup, [a] -16° (c, 1% i ethanol). Ma-The 3Q Isomer B product of Example 16 (1.05 g, 0.028 mol) is hydrolyzed with 2 ml of concentrated ammonia in 5 ml of water according to the procedure of Example 2 to give 0.9 g (97%) (8S) -7- ( 3-mercapto-2-trifluoromethyl-1-oxopropyl) -1,4-dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid, isomer B as a pale yellow viscous syrup, [a] - 16 ° (c, 1% in ethanol). Must-

DK 159115BDK 159115B

2828

OISLAND

terialet størkner til et voksagtigt fast stof, smeltepunkt 61-64°C (s 55°).the solid solidifies to a waxy solid, mp 61-64 ° C (s 55 °).

Analyse, beregnet for C11H14F3NO5S.0,25 H20: C 39,58, H 4,38, N 4,20, S 9,61, F 17,01.Analysis calculated for C 11 H 14 F 3 NO 5 S.0.25 H 2 O: C 39.58, H 4.38, N 4.20, S 9.61, F 17.01.

5 Fundet: C 39,60, H 4,28, N 4,26, S 9,62, F 16,89.Found: C, 39.60; H, 4.28; N, 4.26; S, 9.62; F, 16.89.

Eksempel 14 [8S]-7-(3-Mercapto-2-trifluormethyl-l-oxopropyl)-7-aza-l,4-dir thiaspiro[4,4]nonan-8-carboxylsyre 10 a) 3-[[(4-Methoxy)phenylmethyl]thio]-2-trifluormethylpropionyl-chloridExample 14 [8S] -7- (3-Mercapto-2-trifluoromethyl-1-oxopropyl) -7-aza-1,4-dir thiaspiro [4,4] nonane-8-carboxylic acid a) 3 - [[( 4-methoxy) phenylmethyl] thio] -2-trifluormethylpropionyl chloride

En omhyggelig blanding af 3,9 g 1-trifluormethyla-A careful mixture of 3.9 g of 1-trifluoromethyl methylene

crylsyre og 4,3 g 4-methoxybenzyltiiiol omrøres ved 100-110°CCrylic acid and 4.3 g of 4-methoxybenzylthiol are stirred at 100-110 ° C

i en time. Blandingen får lov at køle af til stuetemperatur, 15 og det faste stof omkrystalliseres ud fra cyclohexan, hvilket giver 3-[[(4-methoxy)phenylmethyl]thio]-2-trifluormethylpro-pionsyre, smeltepunkt 72-74°C.for one hour. The mixture is allowed to cool to room temperature, 15 and the solid is recrystallized from cyclohexane to give 3 - [[(4-methoxy) phenylmethyl] thio] -2-trifluoromethylpropionic acid, mp 72-74 ° C.

Behandling af denne syre med thionylchlorid giver 3-[[(4-methoxy)phenylmethyl]thio]-2-trifluormethylpropionyl- 20 chlorid.Treatment of this acid with thionyl chloride gives 3 - [[(4-methoxy) phenylmethyl] thio] -2-trifluoromethylpropionyl chloride.

b) [8S] —7— [3— [ [ (4-Methoxy) phenylmethyl] thio] - 2-trif luorme thyl--1-oxopropyl]-7-aza-l,4-dithiaspiro[4,4]nonan-8-carboxyl-syre 3- [ [ (4-Methoxy)phenylmethyl] thio]-2-trifluormethyl- 25 propionylchloridet fra del (a) omsættes med 4,4-ethylendithio--L-prolin ifølge fremgangsmåden i eksempel 9(d), hvilket giver [8S]-7-[3-[[(4-methoxy)phenylmethyl]thio]-2-trifluorme-thyl-l-oxopropyl]-7-aza-l,4-dithiaspiro[4,4]nonan-8-carboxyl- syre.b) [8S] -7- [3 - [[(4-Methoxy) phenylmethyl] thio] -2-trifluoromethyl-1-oxopropyl] -7-aza-1,4-dithiaspiro [4,4] nonane The 8-carboxylic acid 3- [[(4-Methoxy) phenylmethyl] thio] -2-trifluoromethylpropionyl chloride from part (a) is reacted with 4,4-ethylenedithio-L-proline according to the procedure of Example 9 (d). ) to give [8S] -7- [3 - [[(4-methoxy) phenylmethyl] thio] -2-trifluoromethyl-1-oxopropyl] -7-aza-1,4-dithiaspiro [4,4] nonan-8-carboxylic acid.

30 c) [8S]-7-(3-Mercapto-2-trifluormethyl-l-oxopropyl)-7-aza--1,4-dithiaspiro[4,4]nonan-8-carboxylsyreC) [8S] -7- (3-Mercapto-2-trifluoromethyl-1-oxopropyl) -7-aza - 1,4-dithiaspiro [4,4] nonane-8-carboxylic acid

Produktet fra del (b) blandes med trifluoreddike- syre og anisol under nitrogen. Opløsningsmidlerne fjernes under vakuum, hvilket som remanens giver [8S]-7-(3-mercap-35 * to-2-trifluormethyl-l-oxopropyl)-7-aza-l,4-dithiaspiro[4,4]-nonan-8-carboxylsyre.The product of part (b) is mixed with trifluoroacetic acid and anisole under nitrogen. The solvents are removed in vacuo to give, as residue, [8S] -7- (3-mercap-35 * to-2-trifluoromethyl-1-oxopropyl) -7-aza-1,4-dithiaspiro [4,4] nonan 8-carboxylic acid.

OISLAND

DK 159115 BDK 159115 B

2929

Eksempel 15 1-(3-Mercapto-l-oxopropyl)-4,4-dimethylthio-L-prolin a) 4-Keto-L-prolin-hydrobromidExample 15 1- (3-Mercapto-1-oxopropyl) -4,4-dimethylthio-L-proline a) 4-Keto-L-proline hydrobromide

Til 4,0 g (0,015 mol) N-carbobenzyloxy-4-keto-L-5 -prolin sættes 20 ml hydrogenbromid i eddikesyre (30-32%). Blandingen hvivles hyppigt om i et tidsrum på 8 minutter.To 4.0 g (0.015 mol) of N-carbobenzyloxy-4-keto-L-5-proline is added 20 ml of hydrogen bromide in acetic acid (30-32%). The mixture is swirled frequently for a period of 8 minutes.

Ved slutningen af dette tidsrum (brusningen er ophørt),dæk-kes den gulorange opløsning med et lag af ether på 25°C, og det gummiagtige produkt tritureres. Etheren kasseres, og 10 det fremkomne klæbrige faste stof tritureres med frisk ether og til sidst med 50 ml acetonitril, hvilket giver 4-keto-L--prolin-hydrobromid som et krystallinsk fast stof, der vejer 2,7 g (85%), smeltepunkt 153-155°C (sønderdeling), [a]^* -49° (c, 1% i vand).At the end of this time (the effervescence has ceased), the yellow-orange solution is covered with a layer of ether of 25 ° C and the rubbery product triturated. The ether is discarded and the resulting sticky solid is triturated with fresh ether and finally with 50 ml of acetonitrile to give 4-keto-L-proline hydrobromide as a crystalline solid weighing 2.7 g (85%) , mp 153-155 ° C (dec.), [α] D -49 ° (c, 1% in water).

15 b) 1-[3-(Aoetylthio-l-oxopropyl]-4-oxo-L-prolinB) 1- [3- (Aoethylthio-1-oxopropyl] -4-oxo-L-proline

En omrørt opløsning af 4,1 g (0,0195 mol) 4-keto--L-prolin-hydrobromid i 50 ml vand afkøles til 5°C og behandles portionsvis med fast natriumcarbonat (skumning reguleres ved tilsætning af nogle dråber ether) til pH 8,0 (ca. 2 g er 20 nødvendigt). Derefter tilsættes portionsvis under fortsat omrøring og afkøling en opløsning af 3,5 g (0,012 mol) 3-acet-ylthiopropanoylchlorid i 5 ml ethylacetat ved hjælp af en pipette, idet pH holdes på 7,0-8,0 ved dråbevis tilsætning af 25% (vægt/volumen) natriumcarbonatopløsning (ca. 10 ml) .A stirred solution of 4.1 g (0.0195 mol) of 4-keto-L-proline hydrobromide in 50 ml of water is cooled to 5 ° C and treated portionwise with solid sodium carbonate (foaming is controlled by the addition of a few drops of ether). pH 8.0 (about 2 g is needed). Then, with continued stirring and cooling, a solution of 3.5 g (0.012 mol) of 3-acetyl ylthiopropanoyl chloride in 5 ml of ethyl acetate is added by pipette, maintaining the pH of 7.0-8.0 by dropwise addition of 25 ml. % (w / v) sodium carbonate solution (about 10 ml).

25 Efter ca. 10 minutters·' forløb stabiliseres pH på 8,0-8,4.25 After approx. For 10 minutes, the pH is stabilized at 8.0-8.4.

Efter fortsat omrøring og afkøling i i alt en time vaskes opløsningen med 2 x 50 ml ethylacetat, dækkes med et lag af 50 ml ethylacetat, omrøres, afkøles, gøres forsigtigt sur med koncentreret saltsyre til pH 2,0, mættes med natrium-30 chlorid, og lagene adskilles. Den vandige fase ekstraheres med yderligere 3 x 50 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, til sidst ved 0,2 mm, hvilket giver 4,8 g af en gulorange glaslignende remanens. Denne remanens opløses i 35 ml ethylacetat og be-35 handles med en opløsning af 3,5 g dicyclohexylamin i 5 ml ethylacetat. Ved podning og gnidning udskilles krystallinsk 0After continued stirring and cooling for a total of one hour, the solution is washed with 2 x 50 ml of ethyl acetate, covered with a layer of 50 ml of ethyl acetate, stirred, cooled, gently acidified with concentrated hydrochloric acid to pH 2.0, saturated with sodium chloride, and the layers separate. The aqueous phase is extracted with an additional 3 x 50 ml of ethyl acetate, the combined organic layers are dried (MgSO4) and the solvent is evaporated, finally at 0.2 mm to give 4.8 g of a yellow-orange glass-like residue. This residue is dissolved in 35 ml of ethyl acetate and treated with a solution of 3.5 g of dicyclohexylamine in 5 ml of ethyl acetate. By grafting and rubbing, crystalline 0 is separated

DK159115BDK159115B

30 1-[3-(acetylthio-1-oxopropyl)]-4-oxo-L-prolin-dicyclohexyl-aminsalt, vægt efter afkøling natten over 2,7 g (næsten farveløs), smeltepunkt 191-193°C (sønderdeling), [a]^ -24° (c, 1% i CHC13).1- [3- (acetylthio-1-oxopropyl)] - 4-oxo-L-proline dicyclohexyl amine salt, weight after cooling overnight 2.7 g (almost colorless), m.p. 191-193 ° C (dec.) , [α] D -24 ° (c, 1% in CHCl3).

5 Dette dicyclohexylaminsalt omdannes til den frie syre ved anvendelse af kaliumbisulfat som beskrevet i eksempel 1(e), hvilket giver 3,7 g l-[3-(acetylthio)-1-oxopropyl]--4-oxo-L-prolin som et bleggult glaslignende fast stof.This dicyclohexylamine salt is converted to the free acid using potassium bisulfate as described in Example 1 (e) to give 3.7 g of 1- [3- (acetylthio) -1-oxopropyl] -4-oxo-L-proline as a pale yellow glass-like solid.

c) 1-[3-(Acetylthio)-1-oxopropyl]-4,4-dimethylthio-L-prolin 10 1-[3-(Acetylthio)-1-oxopropyl]-4-oxo-L-?rolinet om sættes med methylthiol ifølge fremgangsmåden i eksempel 9(a), hvilket giver 1-[3-(acetylthio)-1-oxopropyl]-4,4-dimethylthio-L-prolin .c) 1- [3- (Acetylthio) -1-oxopropyl] -4,4-dimethylthio-L-proline 1- [3- (Acetylthio) -1-oxopropyl] -4-oxo-L-rololine with methylthiol according to the procedure of Example 9 (a) to give 1- [3- (acetylthio) -1-oxopropyl] -4,4-dimethylthio-L-proline.

d) 1-(3-Mercapto-l-oxopropyl)-4,4-dimethylthio-L-prolin 15 Produktet fra del (a) hydrolyseres med koncentre ret ammoniak ifølge fremgangsmåden i eksempel 2, hvilket giver 1-(3-mercapto-1-oxopropyl)-4,4-dimethylthio-L-prolin.d) 1- (3-Mercapto-1-oxopropyl) -4,4-dimethylthio-L-proline The product of part (a) is hydrolyzed with concentrated ammonia concentrate according to the procedure of Example 2 to give 1- (3-mercapto- 1-oxopropyl) -4,4-dimethylthio-L-proline.

Eksempel 16 20 [7(S),8Sj-7-(3-Mercapto-2-methyl-1-oxopropyl)-1,4-dioxo-7-aza- spiro[4,4]nonan-2-methyl-8-carboxylsyre a) N-Carbobenzyloxy-4,4-(1-methylethylendioxy)-L-prolin-methyl-esterExample 16 [7 (S), 8Sj-7- (3-Mercapto-2-methyl-1-oxopropyl) -1,4-dioxo-7-azispiro [4,4] nonan-2-methyl-8 -carboxylic acid a) N-Carbobenzyloxy-4,4- (1-methylethylenedioxy) -L-proline methyl ester

En omrørt blanding af 8 g (0,025 mol) N-carbobenz-25 yloxy-4,4-dimethoxy-L-prolin-methylester fra eksempel 3(a), 2,4 g (0,032 mol) 1,2-propandiol, 0,4 g p-toluensulfonsyre-mo-nohydroat og 400 ml toluen opvarmes til tilbagesvaling (110-112°C). Tilbagesvalingshastigheden reguleres således, at opløsningsmidlet langsomt destillerer ved hjælp af en Dean-30 Stark-ledning ind til en skalainddelt cylinder. Når der er opn samlet 80 ml opløsningsmiddel, sættes en tilsvarende volumen frisk opløsningsmiddel til reaktionskolben gennem en tilsætningstragt. Denne operation med at fjerne og erstatte 80 ml opløsningsmiddel gentages fire gange under en sam-35 let tilbagesvalingsperiode på 1,25 time.A stirred mixture of 8 g (0.025 mole) of N-carbobenzyloxy-4,4-dimethoxy-L-proline methyl ester from Example 3 (a), 2.4 g (0.032 mole) of 1,2-propanediol, 0 , 4 g of p-toluenesulfonic acid monohydroate and 400 ml of toluene are heated to reflux (110-112 ° C). The reflux rate is controlled so that the solvent slowly distills by means of a Dean-30 Stark line into a scale cylinder. When 80 ml of solvent has been collected, a corresponding volume of fresh solvent is added to the reaction flask through an addition funnel. This operation of removing and replacing 80 ml of solvent is repeated four times during a total reflux period of 1.25 hours.

OISLAND

DK 159115 BDK 159115 B

3131

Efter henstand natten over vaskes blandingen med 2 x 100 ml vand, de forenede vaskninger ekstraheres tilbage med 100 ml toluen, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet fjernes på en roterende fordamper, til 5 sidst ved 0,2 mm, hvilket giver 8,2 g (99%) N-carbobenzyl-oxy-4,4-(1-methylethylendioxy)-L-prolin-methylester som en gul viskos olie.After standing overnight, the mixture is washed with 2 x 100 ml of water, the combined washes extracted with 100 ml of toluene, the combined organic layers are dried (MgSO 4) and the solvent is removed on a rotary evaporator, finally at 0.2 mm. to give 8.2 g (99%) of N-carbobenzyl-oxy-4,4- (1-methylethylenedioxy) -L-proline methyl ester as a yellow viscous oil.

b) N-Carbobenzyloxy-4,4- (1-meth.ylethylendioxy) -L-prolinb) N-Carbobenzyloxy-4,4- (1-methylethylenedioxy) -L-proline

Det rå methylesterprodukt fra del (a) (8,2 g, 10 0,025 mol) opløses i 80 ml methanol, behandles dråbevis ved -1 til +4°C med 18 ml (0,036 mol) 2N natriumhydroxid, holdes ved 0°C i en time og ved stuetemperatur natten over. Efter at ca. halvdelen af opløsningsmidlet er fjernet på en roterende fordamper, fortyndes opløsningen med 150 ml vand, va-15 skes med 100 ml ether (vaskevæsken kasseres), gøres sur under afkøling med 6,3 ml 1:1 saltsyre til pH 2 og ekstraheres med ethylacetat (4 x 75 ml). De forenede ekstrakter vaskes med 50 ml mættet natriumchlorid, tørres (MgSO^), og opløsningsmidlet afdampes, hvilket giver 8 g rødorange viskos olie.The crude methyl ester product of part (a) (8.2 g, 10 0.025 mol) is dissolved in 80 ml of methanol, treated dropwise at -1 to + 4 ° C with 18 ml (0.036 mol) of 2N sodium hydroxide, maintained at 0 ° C one hour and at room temperature overnight. After approx. half of the solvent is removed on a rotary evaporator, diluted with 150 ml of water, washed with 100 ml of ether (the wash liquid discarded), acidified with cooling with 6.3 ml of 1: 1 hydrochloric acid to pH 2 and extracted with ethyl acetate (4 x 75 ml). The combined extracts are washed with 50 ml of saturated sodium chloride, dried (MgSO4) and the solvent is evaporated to give 8 g of red orange viscous oil.

20 Denne olie opløses i 50 ml acetonitril, opvarmes, omrøres og behandles med 3,8 g 1-adamantanamin. Det faste salt udskilles hurtigt. Efter afkøling natten over filtreres materialet, vaskes med kold acetonitril og med ether og tørres i vakuum, hvilket giver 10,3 g råt adamantanaminsalt, smel-25 tepunkt 202-204°C (sønderdeling), [a]^ -13° (c, 1% i methanol) . Efter triturering med 50 ml kogende acetonitril og afkøling vejer det svagt lysebrune salt 9,4 g, smeltepunkt 202-204°C, sønderdeling, [a]^6 -13° (c, 1% i methanol).This oil is dissolved in 50 ml of acetonitrile, heated, stirred and treated with 3.8 g of 1-adamantanamine. The solid salt is rapidly excreted. After cooling overnight, the material is filtered, washed with cold acetonitrile and ether and dried in vacuo to give 10.3 g of crude adamantanamine salt, m.p. 202-204 ° C (dec.), [Α] D -13 ° (c , 1% in methanol). After trituration with 50 ml of boiling acetonitrile and cooling, the slightly pale brown salt weighs 9.4 g, m.p. 202-204 ° C, decomp., [Α] D 6 -13 ° (c, 1% in methanol).

Ovennævnte adamantanaminsalt suspenderes i 40 ml 30 ethylacetat, omrøres og behandles med IN saltsyre. Når der er opnået to klare lag, adskilles disse, den vandige fase ekstraheres med yderligere 3 x 40 ml ethylacetat, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet af-dampes, til sidst ved 0,2 mm og 40UC, hvilket giver 5,8 g 35 (72%) N-carbobenzyloxy-4,4-(1-methylethylendioxy)-L-prolin som en gulorange viskos sirup.The above adamantanamine salt is suspended in 40 ml of ethyl acetate, stirred and treated with 1N hydrochloric acid. When two clear layers are obtained, these are separated, the aqueous phase is extracted with an additional 3 x 40 ml of ethyl acetate, the combined organic layers are dried (MgSO 4) and the solvent is evaporated, finally at 0.2 mm and 40UC, gives 5.8 g (72%) of N-carbobenzyloxy-4,4- (1-methylethylenedioxy) -L-proline as a yellow-orange viscous syrup.

DK 159115 BDK 159115 B

3232

OISLAND

c) 4,4-(l-Methylethylendioxy)-L-prolinc) 4,4- (1-Methylethylenedioxy) -L-proline

En opløsning 5,6 g (0,017 mol) af ovennævnte N--carbobenzyloxy-4,4- (1-methylethylendioxo) -L-prolin i 150 ml 2:1 methanol/vand behandles med 1,6 g 5% palladium-carbon-5 -katalysator og rystes under 3 atm. hydrogen i 5 timer. Katalysatoren filtreres fra under nitrogen, vaskes med methanol og de forenede filtrater inddampes, til sidst ved 0,1-0,2 mm, hvilket giver en krystallinsk remanens. Denne suspenderes i 200 ml methanol, og inddampningen gentages. Den faste re-10 manens gnides under ether (inddampning gentages), hvilket giver 3,0 g (94%) bleg lysebrunt 4,4-(1-methylethylendioxy)- -L-prolin, smeltepunkt 219-221°C (sønderdeling) med forudgå- 25 o ende gradvis mørkfarvning og sintring, [a] Q -22 (c, 1% i 1:1 ethanol/vand).A solution of 5.6 g (0.017 mol) of the above N - carbobenzyloxy-4,4- (1-methylethylenedioxo) -L-proline in 150 ml of 2: 1 methanol / water is treated with 1.6 g of 5% palladium carbon. -5 catalyst and shaken for 3 atm. hydrogen for 5 hours. The catalyst is filtered off under nitrogen, washed with methanol and the combined filtrates evaporated, finally at 0.1-0.2 mm to give a crystalline residue. This is suspended in 200 ml of methanol and the evaporation is repeated. The solid residue is rubbed under ether (evaporation repeated) to give 3.0 g (94%) pale pale brown 4,4- (1-methylethylenedioxy) -L-proline, mp 219-221 ° C (dec.) with prior gradual darkening and sintering, [α] Q -22 (c, 1% in 1: 1 ethanol / water).

15 d) [7(S),8S]-7-[3-(Acetylthio)-2-methyl-l-oxopropyl3-1,4-di-oxo-7-azaspiro[4,4]nonan-2-methyl-8-carboxylsyre 2,8 g (Q',015 mol) af 4,4-(1-methylethylendioxy)--L-prolinet omsættes med 3,0 g (0,017 mol) D-3-acetylthio-2--methylpropionylchlorid i 40 ml vand ifølge fremgangsmåden i 20 eksempel 1(e), hvilket giver 5,0 g viskost gult produkt. Dette behandles med 2,8 g dicyclohexylamin i 45 ml ethylacetat, hvilket giver 4,2 g næsten farveløst [7(S),8S]-7-[3-(acetylthio) -2-methyl-l-oxopropyl]-1,4-dioxo-7-azaspiro[4,4]nonan--2-methyl-8-carboxylsyre-dicyclohexylaminsalt, smeltepunkt 25 170-172°C (s, 168°C> [a]^5 -58°, (c, 1% i ethanol). Efter krystallisation ud fra 12 ml acetonitril vejer det farveløse faste salt 3,85 g (51%), smeltepunkt 170-172°C (s, 168°C), [a]^5 -57° (c, 1% i ethanol).D) [7 (S), 8S] -7- [3- (Acetylthio) -2-methyl-1-oxopropyl3-1,4-dioxo-7-azaspiro [4,4] nonan-2-methyl -8-carboxylic acid 2.8 g (Q ', 015 mol) of 4,4- (1-methylethylenedioxy) - The L-proline is reacted with 3.0 g (0.017 mol) of D-3-acetylthio-2-methylpropionyl chloride in 40 ml of water according to the procedure of Example 1 (e) to give 5.0 g of viscous yellow product. This is treated with 2.8 g of dicyclohexylamine in 45 ml of ethyl acetate to give 4.2 g of almost colorless [7 (S), 8S] -7- [3- (acetylthio) -2-methyl-1-oxopropyl] -1, 4-dioxo-7-azaspiro [4,4] nonane-2-methyl-8-carboxylic acid dicyclohexylamine salt, m.p. 170-172 ° C (s, 168 ° C> [α] 5-58 °, (c After crystallization from 12 ml of acetonitrile, the colorless solid salt weighs 3.85 g (51%), m.p. 170-172 ° C (s, 168 ° C), [.alpha. (c, 1% in ethanol).

Analyse, beregnet for C-^H^-jNOgS.C^I^gN: 30 C 60,90, H 8,65, N 5,46, S 6,26.Analysis calculated for C- HH ^jNOgS.C ^ I ^N: 30 C 60.90, H 8.65, N 5.46, S 6.26.

Fundet: C 60,93,.H 8,72, N 5,43, S 6,35. Dicyclohexylaminsaltet omdannes til den frie syre ved at suspendere 3,8 gi ethylacetat og behandle med 45 ml 10% kaliumbisulfat og omrøre, indtil der fås to lag.Found: C, 60.93; H, 8.72; N, 5.43; S, 6.35. The dicyclohexylamine salt is converted to the free acid by suspending 3.8 g of ethyl acetate and treating with 45 ml of 10% potassium bisulfate and stirring until two layers are obtained.

35 Efter adskillelse ekstraheres den vandige fase med ethylacetat (4 x 40 ml), de organiske lag forenes, tørres (MgS04),After separation, the aqueous phase is extracted with ethyl acetate (4 x 40 ml), the organic layers are combined, dried (MgSO 4),

OISLAND

DK 159115BDK 159115B

33 og opløsningsmidlet afdampes, hvilket giver 2,5 g (51%) farveløs fast [7(S),8S]-7-[3-(acetylthio)-2-methyl-l-oxopro-pyl]-l,4-dioxo-7-azaspiro[4,4]nonan-2-methyl-8-carboxylsyre, smeltepunkt 65-68°C (s, 48°C) , [a]^5 -100° (c, 1% i ethanol).And the solvent is evaporated to give 2.5 g (51%) of colorless solid [7 (S), 8 S] -7- [3- (acetylthio) -2-methyl-1-oxopropyl] -1,4 dioxo-7-azaspiro [4,4] nonan-2-methyl-8-carboxylic acid, m.p. 65-68 ° C (s, 48 ° C), [α] 5 -100 ° (c, 1% in ethanol) .

5 e) [7(S) ,8SJ-7-(3-mercapto-2-methyl-l-oxopropyl)-l,4-dioxo- -7-azaspiro[4,4]nonan-2-methyl-8-carboxylsyreE) [7 (S), 8SJ-7- (3-mercapto-2-methyl-1-oxopropyl) -1,4-dioxo-7-azaspiro [4,4] nonan-2-methyl-8- carboxylic acid

Produktet fra del (d) hydrolyseres med koncentreret ammoniak ifølge fremgangsmåden i eksempel 2, hvilket giver 2.05 g [7(S),8S]-7-(3-mercapto-2-methyl-l-oxopropyl)-1,4-di- 10 oxo-7-azaspiro[4,4]nonan-2-methyl-8-carboxylsvre som en vi- 25 o skos farveløs olie, [a] D -57 , (c, 1% i ethanol).The product of part (d) is hydrolyzed with concentrated ammonia according to the procedure of Example 2 to give 2.05 g of [7 (S), 8S] -7- (3-mercapto-2-methyl-1-oxopropyl) -1,4-di 10 oxo-7-azaspiro [4,4] nonan-2-methyl-8-carboxylic acid as a viscous colorless oil, [α] D -57, (c, 1% in ethanol).

Eksempel 17 (S,S,S,S)-7,7'-[Dithiobis(2-methyl-l-oxo-3,l-propandiyl)]-15 bis [ 1,4-dioxa- 7-azaspiro [4,4] nonan-8--carboxvlsyre 3,0 g (0,0109 mol) [7(S),8S]-7-(3-Mercapto-2-meth-yl-l-oxopropyl)-1,4-dioxa-7-azaspiro[4,4]nonan-8-carboxylsy-re fra eksempel 2 opløses i 80 ml vand, og pH indstilles til 6.5 med IN natriumhydroxid. Til denne omrørte opløsning sæt-20 tes dråbevis i alt 11 ml 0,5 molær iodopløsning i 95% ethanol (6,34 g iod/50 ml opløsning), idet pH holdes på 5,5-6,5 med IN natriumhydroxid. Efter 15 minutter fjernes spor af overskydende iod med fortyndet natriumthiosulfat, og opløsningen koncentreres til ca. 50 ml, afkøles og gøres sur med 25 1:1 saltsyre. 30 ml methylenchlorid tilsættes, og blandin gen mættes med natriumchlorid, omrøres, og lagene adskilles.Example 17 (S, S, S, S) -7,7 '- [Dithiobis (2-methyl-1-oxo-3,1-propanediyl)] - 15 bis [1,4-dioxa-7-azaspiro [4 , 4] nonan-8-carboxylic acid 3.0 g (0.0109 mol) [7 (S), 8S] -7- (3-Mercapto-2-methyl-1-oxopropyl) -1,4- Dioxa-7-azaspiro [4,4] nonane-8-carboxylic acid from Example 2 is dissolved in 80 ml of water and the pH is adjusted to 6.5 with 1N sodium hydroxide. To this stirred solution, a total of 11 ml of 0.5 molar iodine solution in 95% ethanol (6.34 g iodine / 50 ml solution) is added dropwise, keeping the pH of 5.5-6.5 with 1N sodium hydroxide. After 15 minutes, traces of excess iodine with dilute sodium thiosulfate are removed and the solution is concentrated to ca. 50 ml, cool and acidify with 25 1: 1 hydrochloric acid. 30 ml of methylene chloride are added and the mixture is saturated with sodium chloride, stirred, and the layers are separated.

Den vandige fase ekstraheres med yderligere 3 x .20 ml methylenchlorid, de forenede organiske lag tørres (MgSO^), og opløsningsmidlet afdampes, til sidst ved 0,2 mm. Den sprøde re-30 manens gnides under ether og afdampningen gentages, hvilket giver 2,8 g bleggul fast remanens. Materialet genopløses i 50 ml methylenchlorid, vaskes med 3 x 10 ml vand, de forenede vandige lag tilbageekstraheres med 20 ml methylenchlorid, og de forenede lag tørres (MgSO^). Inddampning og triture-35 ring med ether som ovenfor giver 2,2 g (73%) flødefarvet 34The aqueous phase is extracted with an additional 3 x .20 ml of methylene chloride, the combined organic layers are dried (MgSO4) and the solvent is evaporated, finally at 0.2 mm. The brittle residue is rubbed under ether and the evaporation repeated, giving 2.8 g of pale yellow solid residue. The material is redissolved in 50 ml of methylene chloride, washed with 3 x 10 ml of water, the combined aqueous layers are back extracted with 20 ml of methylene chloride and the combined layers are dried (MgSO 4). Evaporation and trituration with ether as above gives 2.2 g (73%) of cream 34

OISLAND

DK 159115 BDK 159115 B

amorft fast stof (S,S,S,S)-7,7'-[dithiobis(2-methyl-l-oxo--3,1-propandiyl)]bis[1,4-dioxa-7-azaspiro[4,4]nonan-8-carbox-ylsyre], smeltepunkt 61-63°C (skumning), (s 50°C) , [a]^ -92°, (c, 1% i ethanol).amorphous solid (S, S, S, S) -7,7 '- [dithiobis (2-methyl-1-oxo-3,1-propanediyl)] bis [1,4-dioxa-7-azaspiro [4 , 4] nonan-8-carboxylic acid], m.p. 61-63 ° C (foaming), (s 50 ° C), [α] -92 °, (c, 1% in ethanol).

5 Analyse, beregnet for ^22^32^2^10^ *^2^: C 46,63, H 6,05, N 4,94, S 11,31.Calcd. For Calcd. 222 ^ 32 ^ 2 ^ 10 ^ * 2 ^: C 46.63, H 6.05, N 4.94, S 11.31.

Fundet: C 46,52, H 6,29, N 4,63, S 10,96.Found: C 46.52, H 6.29, N 4.63, S 10.96.

Den biologiske virkning af forbindelserne fremstillet ίο ifølge opfindelsen i sammenligning med captopril, som er kendt fra dansk patentansøgning nr. 596/77, fremgår af den følgende tabel.The biological effect of the compounds prepared according to the invention in comparison with captopril, which is known from Danish Patent Application No. 596/77, is shown in the following table.

*50^ % Inhibering(k) ?H3 ΓΊ* 50 ^% Inhibition (k)? H3 ΓΊ

15 HS-CH.-CH-CO-N L-COOHHS-CH.-CH-CO-N L-COOH

2 0,005 3 (Captopril) c« 52 r,n | 3 0,0008 102 0.005 3 (Captopril) c «52 r, n | 3 0.0008 10

hs-ch2-ch-co-n-1—C00HHS-CH 2 -CH-co-N-1-C00H

CH3"1 1 o^r6 CH3 0,002 16CH3 "1 1 o ^ r6 CH3 0.002 16

25 HS-CH2~CH-C0-N '—CQOHHS-CH2 ~ CH-CO-N '- CQOH

ΓΊ ?H3 0,002 52 HS-CH2-CH-C0-N—l-cooh 30 (3) 150 er den koncentration af den undersøgte forbindelse (/xg/ml), der giver 50% inhibering af angiotensin-omdan-nende enzym isoleret fra kaninlunge.H? H3 0.002 52 HS-CH2-CH-CO-N-1-COOH 30 (3) 150 is the concentration of the compound under investigation (µg / ml) which provides 50% inhibition of angiotensin converting enzyme isolated from rabbit lung.

(b) Tilbageværende procentisk inhibering af angiotensin-om-dannende enzym efter 24 timer hos rotter, som målt ved 35 blodtrykket efter intravenøs infusion af angiotensin I.(b) Residual percent inhibition of angiotensin-forming enzyme after 24 hours in rats, as measured by blood pressure following intravenous infusion of angiotensin I.

DK 159115BDK 159115B

3535

Dosering af forbindelse - 10 mg/kg ækvivalenter af cap-topril.Dosage of compound - 10 mg / kg equivalents of cap-topril.

55

Som det fremgår af resultaterne, er de ved fremgangsmåden ifølge opfindelsen fremstillede forbindelser 3-5 gange så virksomme som captopril, og deres virkning har en betydelig længere varighed, idet der efter 24 timer resterer en 10 betydelig højere procentisk inhibering.As can be seen from the results, the compounds prepared by the process of the invention are 3-5 times as effective as captopril, and their effect has a significantly longer duration, leaving a significantly higher percentage inhibition after 24 hours.

Claims (2)

1. Analogifremgangsmåde til fremstilling af et ketal-eller thioketalderivat af en mercaptoacylprolin med den almene formel 1 5 R1 R2 X1 .X2 X R3 0 ( Λ (I) c i il i * iAn analogous process for preparing a ketal or thioketal derivative of a mercaptoacyl proline of the general formula 1 R 2 X 1 X 2 X R 3 0 (Λ (I) c i 10 R5-S- (CH2 ) m-CH-C-N-C-COOR H hvori R betyder hydrogen eller C^-Cy-alkyl, R3 betyder hydrogen, C1-C7-alkyl eller halogen-C-^-Cy-alkyl,R 5 -S- (CH 2) m-CH-C-N-C-COOR H wherein R is hydrogen or C 1 -C 5 alkyl, R 3 is hydrogen, C 1 -C 7 alkyl or halogen-C 1 -C 6 -alkyl, 15 X1 og X2 betyder oxygen eller svovl, R1 og R2 betyder C1-C7-alkyl, eller R1 og R2 betyder tilsammen en polymethylenkæde, således at der dannes en 5- eller 6-leddet ring, m betyder 0, 1 eller 2, ogX1 and X2 represent oxygen or sulfur, R1 and R2 represent C1-C7 alkyl, or R1 and R2 together form a polymethylene chain to form a 5- or 6-membered ring, m means 0, 1 or 2, and 20 R5 betyder hydrogen, C2-C8-alkanoyl, benzoyl eller en gruppe R1 R2 yl v2 R3 O / f 11 f*lR5 means hydrogen, C2-C8 alkanoyl, benzoyl or a group R1 R2 yl v2 R3 O / f 11 f * l 25 -S- (CH2) m-CH-C-N-C-COOR H hvori R, R1, R2, R3, X1, X2 og m har de ovenfor angivne betydninger, således at der dannes en bis-symmetrisk disul-fidforbindelse, 30 kendetegnet ved, at en substitueret prolin med formlen II 35 DK 159115B R1 R2 X1 i2 X (II) h2c ce2-S- (CH2) m-CH-CNC-COOR H wherein R, R1, R2, R3, X1, X2 and m have the meanings given above to form a bis-symmetric disulphide compound, characterized by that a substituted proline of the formula II X2 (II) h2c ce2 5 HN--C-COOR H hvori R, R1, R2, X1 og X2 har de ovenfor angivne betydninger, kobles med en syre med formlen III R3 c IHN - C-COOR H wherein R, R1, R2, X1 and X2 have the meanings given above are coupled with an acid of formula III R3 c I 10 R,5-S-(CH2)m-CH-COOH (III) • 3 hvori R har den ovenfor angivne betydning, og R'5 betyder C2-C8~alkanoyl eller benzoyl, eller et reaktivt derivat deraf, såsom et syrechlorid, til dannelse af en forbindelse med formlen IV 15 R1 R2 li I, *vx2 „ f p / ^ (iv)Wherein R is as defined above and R 5 is C 2 -C 8 alkanoyl or benzoyl, or a reactive derivative thereof, such as an acid chloride , to form a compound of formula IV, R1, R2, R2, I, * vx2 "fp / ^ (iv) 20 R,5-S-(CH2)m-CH-C-N-C-COOR H hvorefter om ønsket gruppen R'® fjernes til dannelse af en forbindelse med formlen I, hvori R5 betyder hydrogen, og denne forbindelse om ønsket oxideres med iod til den bis-25 -symmetriske disulfidforbindelse.R 5, 5-S- (CH 2) m-CH-CNC-COOR H and then, if desired, the group R 1 is removed to form a compound of formula I wherein R 5 is hydrogen and, if desired, this compound is oxidized with iodine to the bis-25-symmetric disulfide compound. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at R'5 betyder C2-C8-alkanoyl eller benzoyl, og at denne gruppe fjernes ved hydrolyse eller ammonolyse til dannelse af den forbindelse med formlen I, hvori R5 betyder 30 hydrogen.Process according to claim 1, characterized in that R 5 represents C 2 -C 8 alkanoyl or benzoyl and this group is removed by hydrolysis or ammonolysis to give the compound of formula I wherein R 5 represents hydrogen.
DK550079A 1978-12-22 1979-12-21 A LOGIC PROCEDURE FOR PREPARING A KETAL OR THIOKETAL DERIVATIVE OF A MERCAPTOACYL PROLINE DK159115C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97231478A 1978-12-22 1978-12-22
US97231478 1978-12-22

Publications (3)

Publication Number Publication Date
DK550079A DK550079A (en) 1980-06-23
DK159115B true DK159115B (en) 1990-09-03
DK159115C DK159115C (en) 1991-02-11

Family

ID=25519507

Family Applications (1)

Application Number Title Priority Date Filing Date
DK550079A DK159115C (en) 1978-12-22 1979-12-21 A LOGIC PROCEDURE FOR PREPARING A KETAL OR THIOKETAL DERIVATIVE OF A MERCAPTOACYL PROLINE

Country Status (31)

Country Link
JP (1) JPS5594357A (en)
AT (1) AT374174B (en)
AU (1) AU533149B2 (en)
BE (1) BE880815A (en)
CA (1) CA1132985A (en)
CH (1) CH642065A5 (en)
CS (1) CS215036B2 (en)
DD (1) DD148338A5 (en)
DE (1) DE2951200A1 (en)
DK (1) DK159115C (en)
ES (2) ES8102094A1 (en)
FI (1) FI70886C (en)
FR (1) FR2444669A1 (en)
GB (1) GB2039478B (en)
GR (1) GR78384B (en)
HK (1) HK15684A (en)
HU (1) HU179644B (en)
IE (1) IE49321B1 (en)
IL (1) IL58930A (en)
IT (1) IT1126841B (en)
LU (1) LU82023A1 (en)
NL (1) NL7909246A (en)
NO (1) NO153569C (en)
NZ (1) NZ192449A (en)
PH (1) PH19213A (en)
PL (1) PL133414B1 (en)
PT (1) PT70620A (en)
SE (1) SE451839B (en)
SU (1) SU1115668A3 (en)
YU (1) YU314879A (en)
ZA (1) ZA796720B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455585A1 (en) * 1979-05-04 1980-11-28 Ono Pharmaceutical Co OXOAMINOACID DERIVATIVES, MANUFACTURING METHOD AND PHARMACEUTICAL COMPOSITION
US4288368A (en) * 1979-07-30 1981-09-08 E. R. Squibb & Sons, Inc. Dithioacylproline derivatives
US4291040A (en) * 1979-10-22 1981-09-22 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US4356182A (en) * 1979-10-22 1982-10-26 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4-disubstituted prolines
HU184082B (en) * 1979-12-29 1984-06-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing 1-3-/3mercapto-/2s/-methyl-propinyl/-pyrrolidine-/2s/-carboxylic acid
US4284624A (en) 1980-05-02 1981-08-18 E. R. Squibb & Sons, Inc. Mixed disulfides
US4316905A (en) * 1980-07-01 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of various 4-substituted prolines
US4311705A (en) * 1980-10-06 1982-01-19 E. R. Squibb & Sons, Inc. Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
US4374131A (en) 1981-04-27 1983-02-15 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinyl-alkanoyl compounds
US4416831A (en) 1981-04-27 1983-11-22 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinylalkanoyl compounds
US4381297A (en) 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4416833A (en) 1981-05-04 1983-11-22 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4555506A (en) * 1981-12-24 1985-11-26 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and use as hypotensives
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4452791A (en) * 1982-03-15 1984-06-05 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
ZA832762B (en) * 1982-04-30 1983-12-28 Squibb & Sons Inc Substituted 4-phenoxy prolines
US4616005A (en) * 1982-06-23 1986-10-07 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4703043A (en) * 1982-06-23 1987-10-27 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive
US4567166A (en) * 1982-07-14 1986-01-28 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinylalkanoyl compounds useful for treating hypertension
US4709046A (en) * 1983-05-09 1987-11-24 E. R. Squibb & Sons, Inc. Acylmercaptoalkanoyl and mercaptoalkanoyl spiro compounds
AU632596B2 (en) * 1989-08-21 1993-01-07 E.R. Squibb & Sons, Inc. Phosphonate substituted amino or imino acids useful as antihypertensives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
US4091024A (en) * 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
IT7851510A0 (en) * 1977-10-28 1978-10-16 Sandoz Ag AMIDES OF CYCLIC AMINO ACIDS THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES
PH15381A (en) * 1978-02-21 1982-12-17 Squibb & Sons Inc Halogen substituted mercaptoacylamino acids
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines

Also Published As

Publication number Publication date
SU1115668A3 (en) 1984-09-23
NL7909246A (en) 1980-06-24
SE451839B (en) 1987-11-02
IT7951167A0 (en) 1979-12-21
PL220609A1 (en) 1980-12-01
LU82023A1 (en) 1980-04-23
CA1132985A (en) 1982-10-05
GB2039478B (en) 1983-02-16
DK550079A (en) 1980-06-23
AU533149B2 (en) 1983-11-03
FI70886B (en) 1986-07-18
NZ192449A (en) 1984-05-31
FI70886C (en) 1986-10-27
FR2444669B1 (en) 1983-06-03
JPS5594357A (en) 1980-07-17
AT374174B (en) 1984-03-26
IE792468L (en) 1980-06-22
ES487180A0 (en) 1980-12-16
NO153569B (en) 1986-01-06
HU179644B (en) 1982-11-29
CS215036B2 (en) 1982-06-25
NO153569C (en) 1986-05-21
AU5371479A (en) 1980-06-26
IE49321B1 (en) 1985-09-18
YU314879A (en) 1983-04-30
IL58930A0 (en) 1980-03-31
SE7910550L (en) 1980-06-23
GB2039478A (en) 1980-08-13
DE2951200A1 (en) 1980-07-10
DK159115C (en) 1991-02-11
ES8102094A1 (en) 1980-12-16
DD148338A5 (en) 1981-05-20
ATA805479A (en) 1983-08-15
ZA796720B (en) 1980-11-26
BE880815A (en) 1980-06-23
FR2444669A1 (en) 1980-07-18
NO794181L (en) 1980-06-24
ES8103039A1 (en) 1981-02-16
IT1126841B (en) 1986-05-21
CH642065A5 (en) 1984-03-30
PL133414B1 (en) 1985-05-31
ES488752A0 (en) 1981-02-16
PT70620A (en) 1980-01-01
PH19213A (en) 1986-02-04
IL58930A (en) 1983-07-31
HK15684A (en) 1984-03-02
GR78384B (en) 1984-09-26
FI794027A (en) 1980-06-23

Similar Documents

Publication Publication Date Title
DK159115B (en) A LOGIC PROCEDURE FOR PREPARING A KETAL OR THIOKETAL DERIVATIVE OF A MERCAPTOACYL PROLINE
US4310461A (en) Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4578474A (en) Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4390695A (en) Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids
US4192945A (en) Process for preparing proline and homoproline derivatives
EP0135349B1 (en) Condensed seven-membered ring compounds and their production and use
CA1168245A (en) Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
NO781392L (en) MARKAPTOALKYLSYLPHONYL-PROLIN DERIVATIVES AND RELATED COMPOSITIONS
US5576324A (en) Quinoline derivatives or salt thereof and remedy for cardiac diseases containing the same
US4296033A (en) 4-Azido-1-mercaptoacyl proline
US4225495A (en) Pyrrolo or pyrido [2,1-c][1,4] thiazines or thiazepines
US4291040A (en) Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines
US3976660A (en) Pyrrolidine derivatives
NO790568L (en) PROCEDURE FOR THE PREPARATION OF HALOGEN-SUBSTITUTED MARKAPTOACYLAMINO ACIDS
US4321383A (en) Heterobicyclo intermediates
NL8700046A (en) 8 ALFA-ACYLAMINOERGOLINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
US4198515A (en) Mercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
EP0095584B1 (en) Substituted 4-phenoxy and 4-phenylthio prolines
US4303662A (en) Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
US4221912A (en) Dithio derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
EP0042639B1 (en) Azido, imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids having hypotensive activity
IE48497B1 (en) Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
US4456761A (en) 4-Substituted dehydroprolines
US4217458A (en) Acylmercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
US4497953A (en) Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids

Legal Events

Date Code Title Description
PBP Patent lapsed